Graduate Theses, Dissertations, and Problem Reports
2022

Preconception substance use and risk of unintended pregnancy
Saima Shafique
WVU School of Public Health, ss0093@mix.wvu.edu

Follow this and additional works at: https://researchrepository.wvu.edu/etd
Part of the Epidemiology Commons, and the Maternal and Child Health Commons

Recommended Citation
Shafique, Saima, "Preconception substance use and risk of unintended pregnancy" (2022). Graduate
Theses, Dissertations, and Problem Reports. 11281.
https://researchrepository.wvu.edu/etd/11281

This Thesis is protected by copyright and/or related rights. It has been brought to you by the The Research
Repository @ WVU with permission from the rights-holder(s). You are free to use this Thesis in any way that is
permitted by the copyright and related rights legislation that applies to your use. For other uses you must obtain
permission from the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license
in the record and/ or on the work itself. This Thesis has been accepted for inclusion in WVU Graduate Theses,
Dissertations, and Problem Reports collection by an authorized administrator of The Research Repository @ WVU.
For more information, please contact researchrepository@mail.wvu.edu.

Preconception substance use and risk of unintended pregnancy
Submitted to
The School of Public Health
West Virginia University
In partial fulfillment of the requirements for the degree of
Doctor of Philosophy in
Epidemiology

Lesley Cottrell, PhD, Chair
Kim E. Innes, MSPH, PhD
Amna Umer, MPH, PhD
Toni Marie Rudisill, PhD
Wei Fang, PhD

Department of Epidemiology

Morgantown, West Virginia
2022
Keywords: Unintended pregnancy, Preconception substance use, Polysubstance use

Abstract
Background: In the United States, unintended pregnancy is a serious public health issue due to
its persistent high prevalence. In the series of three studies, our first two investigations examined
the risk and potential determinants of unintended pregnancy among substance and polysubstance
using women of childbearing age. In the third study, we conducted a systematic review (SR)
with meta-analysis (MA) to assess the association of illicit and recreational drugs to the risk of
unintended pregnancy.
Methods: We performed a secondary data analysis on a subset of Pregnancy Risk Assessment
Monitoring System (PRAMS) 2016-17 phase 8 data (n=75,543). The outcome variable was
pregnancy intention. The exposure variable was substance use, including alcohol, cannabis,
nicotine/tobacco, illicit/recreational drugs, and special medications, including prescription
opioids, over-the-counter pain relief, and antidepressants. In the second study, the exposure
variable was the use of alcohol in concert with other substances. We also evaluated the relation
of specific sociodemographic and economic variables to the risk of unintended pregnancy. Data
were analyzed using complex survey analysis. For the SR with MA, predetermined criteria were
used to ascertain study eligibility. To identify eligible original studies for the full review, we
screened abstracts from six electronic databases (PubMed (MEDLINE), Scopus, CINAHL,
PsychINFO, and Web of Science) and citation indices from retrieved articles and recent reviews.
The inverse variance method was used to calculate the pooled effect size.
Results: Overall, 41% of pregnancies were unintended. Approximately 57% of participants
reported alcohol consumption, 17% reported smoking, and 10% cannabis use prior to
conception. Study 1: Likelihood of unintended pregnancy was significantly associated with
substance use, including cigarettes (Adjusted Odds Ratio (AOR):1.5, 95% CI: 1.4-1.6); use of
other nicotine/tobacco products (AOR:1.4, 95% CI: 1.3-1.5); cannabis (AOR: 1.9, 95% CI: 1.52.3); illicit/recreational drugs (AOR:1.7, 95% CI: 1.2-2.4), prescription opioids (AOR:1.4, 95%
CI: 1.02-1.9), and prescription antidepressants (AOR 1.8, 95% CI: 1.1-3.0). Among substance
users, factors significantly associated with unintended pregnancy included maternal age <17,
living in urban areas, lower educational attainment, annual income <FPL, not being married, and
poor mental health. Study 2: The likelihood of unintended pregnancy was significantly elevated
in those reporting co-use of alcohol with cigarette smoking (AOR: 1.5, 95%CI:1.4 – 1.6),
cannabis (AOR: 2.0, 95%CI:1.6 – 2.4), tobacco/nicotine (AOR: 1.6, 95%CI:1.4 – 1.7), and
illicit/recreational drugs (AOR: 1.8, 95%CI: 1.1 – 2.7). In addition, living in urban areas, income
below the federal poverty level, and not being married were significant predictors of unintended
pregnancy. Study 3: Our SR with MA included eight observational studies (N=38,520 women).
Pooled findings indicated that illicit and recreational drugs use during the preconception period
was significantly and positively associated with the likelihood of unintended pregnancy (pooled
odds ratio (POR)=1.84, 95% CI: 1.4-2.4).
Conclusion: Findings of our two studies in a large representative sample of US women suggest
that substance and polysubstance use during the preconception period significantly increases the
likelihood of unintended pregnancy. Consistent with these results, the pooled findings of our SR
with MA indicated a significant and positive association between the use of illicit and
recreational drugs and the risk of unintended pregnancy. Collectively, these findings support a
potential causal link between preconception substance use and subsequent risk of unintended
pregnancy. These findings highlight the need for tailored screening, educational, and treatment
programs and integrated family planning services to help reduce both substance use and
unintended pregnancy among women of childbearing age.
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Chapter 1
Introduction and Background
Unintended pregnancy
Unintended pregnancy remains a significant public health issue in the United States
(US). 1 The persistent high prevalence of unintended pregnancies indicates unmet sexual and
reproductive healthcare needs of women of reproductive age. 2 Experiencing unintended
pregnancy is associated with poor health and lower psychological well-being of women and their
families. 3-4 About half of unintended pregnancies end in abortions, and nearly half are live births,
with both outcomes having personal, social, and economic consequences. 5 In 2010, the resulting
national costs from unintended pregnancies leading to miscarriages, abortions, and births were
approximately $21 billion. 6
An unintended pregnancy occurs when no children or no more children are desired, or it
happens earlier than planned, i.e., unwanted or mistimed. 7 While ambivalent pregnancies are
defined as "unresolved or contradictory feelings about whether one wants to have a child at
pregnancy recognition." 8 Unintended pregnancies are associated with delayed and inadequate
prenatal care, poor birth outcomes, including but not limited to premature birth, low birth weight
(LBW), and poor child health and development. 9 It is noted that unwanted pregnancies had
higher odds of preterm delivery, 10 while women who were ambivalent about their pregnancies
had higher odds of having an LBW infant. 11 The evidence about mistimed pregnancies causing
LBW is inconsistent. 12,13 It is reported that women with unintended pregnancies are less likely to
modify harmful behaviors, less vigilant in detecting maternal health problems and practicing
healthy behaviors. 14-15 Women with unintended pregnancies are more likely to experience
household dysfunction, psychological and physical abuse. 16A systematic review and meta-
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analysis on the association between unintended pregnancy and perinatal depression revealed a
two-fold prevalence of perinatal depression with unintended pregnancy. 17 Given the high
prevalence of unintended pregnancies and their impact on maternal and child health, prevention
efforts should be given a public health priority.

Risk factors of Unintended Pregnancy
Although all women of childbearing age (15-44) years are at risk of unintended
pregnancy, sexually active, fertile, and women neither their partners using contraception and not
trying to become pregnant are considered in this pool.4 Unintended pregnancy has been attributed
to a range of demographic, social, economic, and behavioral risk factors. These factors include
maternal age, race, levels of education, socioeconomic status, marital status, pregnancy history,
mental health, maternal childhood experiences, physical or emotional abuse, and substance use.
Studies on maternal age show that teenage women are more likely to describe their
pregnancy as unintended than older women. 18 However, some studies have suggested that
women aged thirty-five years or older are more likely to describe their pregnancies as unintended
as they may already have the desired number of children. 19 Usually, women at the beginning or
end of their childbearing age are more likely to experience unintended pregnancy; however, a
study shows that women from 18-24 years of age made the most significant proportion of
unintended births, i.e., 81 per 1000 women. 1
Racial and ethnic minorities women are more likely to experience unintended
pregnancies and births than White women. A study based on the National Survey of Family
Growth exploring racial/ethnic differences in unintended pregnancies noted a higher prevalence
of unintended pregnancy among Black (63%), followed by Hispanics (48%) compared to White
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women (42%). 20 In another study, 16% of Black women of childbearing age compared with 9%
of Asian, Hispanic, or White women were not using contraception. 21
Women with less than or equal to high school education were at higher risk of unintended
pregnancy than women with graduate education. Moreover, women with less than or equal to a
high school diploma perceive that pregnancy may jeopardize their educational or career
aspirations. 22
Low socioeconomic status is known as an independent risk factor for unintended
pregnancy. 23Women who are young, unmarried, and have low socioeconomic status have
disproportionately higher levels of unintended childbearing. 24This also raises the question of
whether the mother's socioeconomic disadvantage or her pregnancy intention leads to poor
health outcomes.
Literature shows that women who do not have a partner were three times more likely to
describe their pregnancy as unintended than those with a partner or significant other. 25 Mothers
with lower social support during pregnancy and conflict within their relationships are less likely
to describe their pregnancy as intended. 26,27Physical and emotional abuse is also associated with
unintended pregnancy. Abusive relationships and an environment of fear may limit women's
fertility control, leading to unintended pregnancy. 28
Data on contraception shows inconsistent, incorrect, or no use of effective contraceptive
methods are associated with a high prevalence of unintended pregnancy. It may happen due to
the perceived low risk of pregnancy, lack of contraceptive knowledge, misperception of side
effects, and barriers to using healthcare services. 29
The impact of mental health on reproductive health and pregnancy outcomes has been a
seldom focus in the scientific literature. Although depression and anxiety are the most common
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health problems linked with risky sexual behaviors, few studies have examined their relationship
with pregnancy intention. A prospective cohort study with a representative sample reported that
women with depression and stress symptoms had higher unintended pregnancy rates than women
without these symptoms. 30Another longitudinal cohort study found a significant association
between adverse life experiences and the risk of unintended pregnancy among adolescents and
young women. 31 In literature, there is a range of factors linked to pregnancy intention. However,
more research is needed to address this public health issue and the underlying disparities in
unintended pregnancy rates.

Substance use among women of childbearing age
Substance use among women of childbearing age is associated with poor physical,
mental, and social health outcomes.15 These substances include tobacco, alcohol, over-thecounter and prescription medicines, and illicit drugs. 32 In a national survey (2012-13)
administered among women ages 15-44, about 24.0% of women reported smoking, 55.4%
alcohol consumption, 27% reported binge drinking, with 4.6% having at least one episode of
binge drinking during the last one-month, and about 11.4% revealed the use of illicit drugs. 33
About one in six women between 15-44 years are prescribed opioid medication annually. 34
The preconception period or the time before pregnancy is crucial for subsequent maternal
and child health. 35 Although most women tend to stop using the substance after pregnancy
recognition, a large proportion of pregnancies are unintended. Pregnancy recognition takes 4-6
weeks after conception, resulting in exposures affecting fetal growth and development. 36 The
adverse effects of substance use during pregnancy on fetal development are well-documented
and widely comprehended. However, data is limited on the preconception substance use
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affecting the newborn infant. A Canadian study on beliefs about the preconception period
revealed that only 38% believed that alcohol consumption during the preconception period might
affect fetal development. 37 Preconception substance use predicts continued or limited usage
during the prenatal period and is linked with poor health outcomes. 38 For example, cigarette
smoking during pregnancy has been associated with LBW, preterm and stillbirth, poor growth,
and reduced cognitive development.14 Alcohol consumption during pregnancy can cause
miscarriage, stillbirth, and Fetal Alcohol Spectrum Disorders (FASDs). 39 The use of cocaine,
cannabis, and Marijuana is linked to preterm labor, small for gestational age (SGA), LBW,
Neonatal Intensive Care Unit (NICU) admissions, poor cognition, and behavior. 40,41,42,43,44
Similarly, the use of heroin and prescription pain medication before pregnancy is associated with
stillbirth, premature birth, and Neonatal Abstinence Syndrome (NAS). 45
Women with substance use suffer poor sexual and reproductive health, inconsistent or
ineffective contraception use, and a high prevalence of unintended pregnancies.29 These women
also face individual and systemic challenges while accessing treatment and family planning
services including, medical and psychological comorbidities, history of neglect and abuse, the
stigma of substance use, emotional and economic difficulties and, fear of losing child custody. 46
A recently published systematic review described women who use substances as a diverse
population based on their sociodemographic, reproductive, and behavioral characteristics. 47
Providers must be aware of the unique needs of these women and the implications surrounding
substance use.15 To provide treatment and family planning services, evidence-based, integrated,
clinical, and behavioral interventions are needed. 48 A systematic review found theory-based
interventions, on-site counseling, and the provision of effective contraception methods more
effective than traditional educational materials. 49 These findings suggest the need for further
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research to determine the characteristics and needs of these women; such information may help
to provide a critical foundation for developing and implementing evidence-based interventions to
prevent unintended pregnancies among substance-using women.

Polysubstance Use
Consuming more than one substance over a period of time is termed polysubstance use.
Polysubstance use can refer to substances used either simultaneously or within the same period. 50
It includes co-use of alcohol, nicotine, cannabis, medical and non-medical prescription
medications, cocaine, heroin, and hallucinogens. 51 In a CDC report, about 40% of pregnant
women who drank alcohol during pregnancy reported co-using other substances, including
tobacco, cannabis, cocaine, and heroin. 52
Although polysubstance use is not a new practice, it is becoming a serious concern due
to high rates of non-medical use of opioids along with other substances. 53 In addition, the policy
changes surrounding efforts to legalize marijuana are also leading to the increasing use of
marijuana concurrently with other substances. 54 Although polysubstance use is common, it
remains underreported due to the associated stigma and legal implications. 55 Polysubstance use
among women of childbearing age raises concerns among public health circles due to its
increasing prevalence and adverse pregnancy and birth outcomes.53 To address this public health
issue, there is a need to understand polysubstance patterns and the sociodemographic factors
predicting poor reproductive health.
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Summary
The US has the highest rates of unintended pregnancy among the developed nations.
These rates are particularly elevated among U.S. women aged 18-24 years, women with low
education attainment, low-income, unmarried, and minority women. 56 More research is needed
to determine the factors underlying disparities in the unintended pregnancy rates.
Previous studies suggest that women who use substances, including tobacco, alcohol,
illicit drugs, and opioids, are at higher risk for unintended pregnancies. 57-58 However,
investigations regarding the association of substance use to unintended pregnancy have to date
been limited to small-scale and hospital-based studies. 59-60 Moreover, to our knowledge, no
studies have yet been conducted in a nationally representative sample to estimate the prevalence
and risk of unintended pregnancy and its subtypes among women with different types of
substance use. To help address this gap, the first aim was to determine the prevalence of
unintended pregnancy in a representative sample of women who use substances and to assess the
associations of sociodemographic factors to unintended pregnancy risk in this population.
Additionally, polysubstance use is another emerging public health challenge with
detrimental effects on maternal and child health. There is a need to identify the prevalence and
patterns of polysubstance use among women of childbearing age to inform effective policies and
practices. For this purpose, our second aim was to investigate the prevalence of polysubstance
use and the risk associated with unintended pregnancy.
Illicit and recreational drugs are a serious public health problem with potentially adverse
maternal and child health effects. 61 According to national statistics, about 19.5 million (15.4%)
of US women above 18 years used illicit and recreational substances. 62 Although many studies
investigated the risk of unintended pregnancy among women using illicit and recreational
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drugs, 63,64,65 these studies vary widely in study population characteristics, study design, and the
determinants assessed. However, to our knowledge, systematic reviews regarding the potential
association of preconception use of illicit and recreational drugs to risk for unintended pregnancy
in women of child-bearing age are lacking. The authors are unaware of any systematic review
(SR) or meta-analysis (MA) that estimated the risk of unintended pregnancy with illicit and
recreational drug use among women of childbearing age. Understanding the link between these
factors is particularly important in light of the high prevalence of substance use and unintended
pregnancy among women of childbearing age. For this purpose, our third study aimed to conduct
a systematic review with meta-analysis to establish evidence essential for policy and practice
efforts to improve maternal and child health.
The long-term goal of this project was to examine the association of unintended
pregnancy with substance use among women of childbearing age. The overall objective of this
project was to determine the associations of unintended pregnancy to preconception substance
use and sociodemographic factors in women of childbearing age. The central hypothesis was that
substance use is an independent risk factor of unintended pregnancies. Precisely, this dissertation
project is planned to investigate the following specific aims.
Specific aims
Specific Aim 1: Examine the association between preconception substance use (alcohol,
smoking, illicit drugs) and unintended pregnancy among women of childbearing age in the US. If
an association exists, compare substance use between subtypes of unintended pregnancies: 1)
mistimed; 2) unwanted and ambivalent.
Aim 1b: Assess the association between sociodemographic factors and unintended
pregnancies among women who use substances.
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Specific Aim 2a: Examine the association between polysubstance use and unintended
pregnancy among women of childbearing age. If a significant association is identified, compare
polysubstance use between sub-types of unintended pregnancies: 1) mistimed, 2) unwanted and
3) ambivalent.
Aim 2b: Assess the association between sociodemographic factors and unintended
pregnancies among women with polysubstance use.

Specific Aim 3: To conduct a systematic review with meta-analysis to assess the relation
of illicit and recreational drugs use and the likelihood of unintended pregnancy among women of
childbearing age.
The three specific aims correspond to chapters two, three, and four, respectively. Chapter
five comprises the overall discussion, including the summary of key findings, strengths,
limitations, potential public health implications, and suggestions and recommendations for future
research. Unintended pregnancy is associated with poor maternal and child health and substantial
economic, healthcare, and individual costs. Thus, determining the risk of unintended pregnancy
among substance-using women of childbearing age and its correlates will aid public health,
policy, and practice efforts to plan and implement informed preventive measures.
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Chapter 2
Preconception Substance Use and Risk of Unintended Pregnancy
Abstract
Objective: This study examined the association between preconception substance use and
unintended pregnancy in a large, nationally representative sample of women.
Methods: In this cross-sectional study, we used data from the Pregnancy Risk Assessment
Monitoring System (PRAMS), comprising 74,543 women who had birth during 2016-17.
Logistic regression was used to assess the independent association of unintended pregnancy
overall and by subtypes to preconception substance use (smoking and other nicotine/tobacco use,
alcohol consumption, and use of cannabis, illicit/recreational drugs) and specific medication,
including prescription opioids, antidepressants and over the counter pain relief. Four highly
prevalent substance use groups were identified for aim 1(b), including alcohol, tobacco/nicotine,
opioids, and illicit/recreational drugs. Stratified descriptive analyses were performed to compare
the sociodemographic indicators among each group. After controlling for potential confounders,
individual models were created for each sociodemographic determinant for each substance-using
group. Logistic regression was used to yield odds ratios with 95%CI and p-value.
Results: Overall, 41% of pregnancies were unintended. Nearly 57% of participants reported
alcohol consumption during the preconception period, with 32% indicating binge drinking, 17%
reported preconception smoking, and 10% cannabis use. Unintended pregnancy was significantly
associated with substance use, including smoking (AOR:1.5, 95% CI: 1.4-1.6); as well as the use
of other nicotine/tobacco (AOR:1.4, 95% CI: 1.3-1.5); cannabis (AOR: 1.9, 95% CI: 1.5-2.3);
illicit/recreational drugs (AOR:1.7, 95% CI: 1.2-2.4), prescription opioids (AOR:1.4, 95% CI:
1.02-1.9), and prescription antidepressants (AOR 1.8, 95% CI: 1.1-3.0). The likelihood of
unintended pregnancy was significantly elevated with heavy smoking, heavy alcohol
consumption, and binge drinking. Analyses by unintended pregnancy subtype yielded similar
results. The sociodemographic determinants of unintended pregnancy among all substance-using
groups including maternal age <17, living in urban areas, not having a graduate degree, annual
income <FPL, not being married, and having depression or anxiety increased the likelihood of
unintended pregnancy, with a varying magnitude of risk. The risk of unintended pregnancy with
race and ethnicity also varied among substance-using groups.
Conclusions: Preconception substance use was significantly and positively associated with
unintended pregnancy. Among all substance-using groups, maternal age <17, living in urban
areas, not having a graduate degree, annual income <FPL, not being married, and having
depression or anxiety increased the risk of unintended pregnancy. This study's findings
underscore the importance of recognizing and addressing preconception substance use among
women of childbearing age. Evidence-based interventions are needed addressing substance use
behavior and effective contraceptive use to prevent unintended pregnancy and related harmful
effects on maternal and child health.

10

Shafique Dissertation

Introduction
Unintended pregnancy increases the risk of adverse outcomes for both maternal and
child. Women with unintended pregnancies are at risk of receiving inadequate prenatal care,
postpartum depression, experiencing depression and anxiety later in their lives, and being less
likely to breastfeed. 66-67 Unintended pregnancy may lead to preterm birth, LBW, and child
maltreatment. 68-69 In the US, about half of the pregnancies are unintended and compared to the
general population, the rates are even higher among women who use substances. 70A study
conducted among opioid-using women revealed that 9 out of 10 pregnancies were unintended. 71
Although the adverse effects of substance use on women's overall health are published in the
literature, little attention has been given to pregnancy intention.15Together; it suggests unmet
reproductive health needs and poor sexual health among substance-using women.
There is a range of sociodemographic, economic, and behavioral risk factors identified
for unintended pregnancy. According to the literature, these factors include lower SES, maternal
age, i.e., adolescence and the end of childbearing age when no more children are desired, lacking
social support, inconsistent or no contraception.1,56 These risk factors tend to be stable across
cultures worldwide. However, a paucity of studies focused on the risk factors of unintended
pregnancy among women who use substances. These women suffer poor sexual and reproductive
health and face challenges while accessing family planning services.46 To address the incidence
of high-risk pregnancies, there is a need to identify the indicators among this high-risk group and
develop and implement interventions to provide counseling and effective contraception. To fill
this gap in the literature, this study aimed to; specific aim 1: examine the association of
preconception substance use (alcohol, smoking, illicit drugs) and unintended pregnancy among
women of childbearing age in the US. If an association exists, compare substance use between
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subtypes of unintended pregnancies: 1) mistimed; 2) unwanted and ambivalent. And aim 1b:
assess the association between sociodemographic factors and unintended pregnancies among
women who use substances.
For this purpose, large national representative data from PRAMS was used. The current
study's findings may underscore the importance of recognizing and addressing preconception
substance use and developing policy and practice measures to reduce unintended pregnancy and
related dire consequences among women of childbearing age.

Materials and Methods
Data Source
We used data from the Pregnancy Risk Assessment Monitoring System (PRAMS) in the
current study. Secondary analysis on a cross-sectional subset of the PRAMS 2016-17 (phase 8)
data was performed. PRAMS is a national, state-specific, population-based surveillance system
that collects maternal and neonatal health indicators' data covering 83% of the US births. 72
Originating in 1987 and designed to monitor maternal and child health indicators, selected
maternal behaviors during preconception, pregnancy, and postpartum periods. PRAMS collects
data from 39 states and New York City. These states include Alaska, Alabama, Arkansas,
Colorado, Connecticut, Delaware, Georgia, Hawaii, Iowa, Illinois, Kansas, Kentucky, Louisiana,
Maine, Maryland, Massachusetts, Michigan, Missouri, Montana, Nebraska, New Hampshire,
New Jersey, New Mexico, New York, North Carolina, North Dakota, Oklahoma, Pennsylvania,
Puerto Rico, Rhode Island, South Dakota, Texas, Utah, Vermont, Virginia, Washington, West
Virginia, Wisconsin, Wyoming. The current minimum response rate threshold for participating
states is 55%.72
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PRAMS Questionnaire
Phase 8 is the most recent PRAMS questionnaire and consists of core questions used by
all states and standard questions as optional selections by the states.
PRAMS data collection
Each state participating in PRAMS draws a stratified systematic sample of 100- 250
women who recently gave birth. Mailed questionnaires or surveys on the phone are used for data
collection. PRAMS data are weighted for sample design, nonresponse, and non-coverage. The
annual sample consists of 1000-3400 women per state. Survey responses have been linked to
birth certificate data and demographic and medical information from the state's vital record
system. Stratified samples drawn from all births make the data representative of women of
childbearing age in each state. PRAMS survey design and methods are explained elsewhere.72
The CDC institutional review board approves the current study. The Institutional review board of
West Virginia University exempted the study from IRB approval (protocol number
1908660609).
Measures:
Women who gave live birth in the United States during 2016-17 were included in the
study. Demographic and background characteristics were generated from the birth certificate
(e.g., age, education, race/ethnicity, marital status) and income, insurance, prenatal care,
substance use, abuse, and childhood adversity from the PRAMS questionnaire.

Pregnancy Intention
The outcome variable pregnancy intention was assessed by responding to the following
question" Thinking back to just before you got pregnant with your new baby, how did you feel
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about getting pregnant? The responses "I wanted to be pregnant then" or "I wanted to be
pregnant sooner" were classified as intended pregnancies. The answer "I wanted to be pregnant
later" was classified as mistimed, "I did not want to be pregnant then or at any time in the future"
was classified as unwanted. The response" I was not sure what I wanted" was categorized as
ambivalent. For binary analysis, mistimed, ambivalent, and unwanted were grouped as
unintended pregnancies based on literature. 73
Substance Use
Smoking was assessed by the yes/no question about smoking three months before pregnancy;
women who answered yes were considered smokers. The smoking intensity (no smoking,
moderate and heavy smoking) was built on the number of cigarettes/ days. Based on the
literature, less than ten cigarettes/day was considered moderate smoking, and ten and more were
regarded as heavy smoking 74.
For alcohol consumption, those responding yes to drinking three months before pregnancy were
categorized as alcohol consumers. The number of alcoholic drinks /week was used to define
moderate (up to 7drinks/week) and heavy drinking (8-14 drinks/week) according to dietary
guidelines for Americans. 75 Binge drinking was defined as having four or more drinks in 2
hours span at least once during three months before pregnancy 76.
The illicit drug/recreational drugs variable was created by combining the yes/no questions
about the use of the following drugs during the month before pregnancy:
1. Adderall, ritalin, or another stimulant
2. Methadone, naloxone, subutex, or suboxone
3. Heroin (smack, junk, black tar, chiva)
4. Amphetamines (uppers, speed, crystal meth, crank, ice, agua)
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5. Cocaine (crack, rick, coke, blow, snow, nieve)
6. Tranquilizers (downers, ludes) hallucinogens (LSD/acid, PCP/angel dust, ecstasy, molly,
mushrooms, bath salts)
7. Sniffing gasoline, glue, aerosol spray cans, or paint to get high (huffing).
Cannabis use was assessed by asking respondents for their use of Marijuana one and three
months before pregnancy.
The variable nicotine and other tobacco forms was created by combining the yes/no variables
about hookah, electronic cigarettes, cigars, cigarillos, flavored cigars, nicotine, betel nut or betel
quid, and chewing tobacco, snuff, snus, and dip. These variables were combined due to fewer
respondents (ranging from 0.7%-6.6%) in each variable.
Among specific medications, prescription antidepressants were defined as the use of
prescribed antidepressant and anti-anxiety medication before pregnancy. Prescription opioids
were defined as the use of prescription pain relievers such as hydrocodone (Vicodin), oxycodone
(Percocet), or codeine before pregnancy. OTC pain relief was assessed using over-the-counter
pain relievers such as aspirin, Tylenol, Advil, or Aleve three months before pregnancy.

Covariates
The covariates include rural/urban status, maternal age, race, ethnicity, level of
education, marital status, poverty, insurance status, parity, adequacy of prenatal care,
maternal childhood experiences, experiencing physical/emotional abuse, and depression and
anxiety were measured as below.
1. Rural/urban status was assigned using National Center of Health Statistics (NCHS)
codes.
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2. Maternal age at conception was categorized as ≤17, 18-24,25-34, and 35+years.

3. Race The Respondents' Race categories include Asian, White, Black, and others. For aim
b, we combined race and ethnicity into a single variable with categories including Asian,
non-Hispanic White, Hispanic White, Black, and others.
4.

Maternal education was categorized using maternal years of education as less than high
school (less than 12), high school (12years), Some college (13-15years), and graduate
(≥16).

5. The poverty status was based on the income-to-needs ratio derived from family income
(median of the income categories) variables and family size (number of dependents plus
self). The poverty threshold adjusted for a family was divided by annual household
income size using the Census Bureau's guidelines to determine the poverty threshold
adjusted for family size (2016-17, respectively). 77 The variable income-to-need ratio was
then dichotomized below the federal poverty level and at or above the federal poverty
level. (<1 below FPL, 1and above/at and above FPL. 78
6. Parity was defined using the categorical question about previous live births.
7. Adequacy of Prenatal Care (PNC) was assessed using the Kessner Index. 79 It is a
composite index defined by a fixed combination of values based on the time of entry into
prenatal care, number of prenatal visits, and the gestational age at the time of birth.
Kessner scale consists of three categories, i.e., adequate PNC, intermediate PNC, and
inadequate PNC. 80 In PRAMS data, unknown PNC was used for incomplete
information.
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8. Health insurance: Pre-pregnancy insurance status was categorized as no insurance,
Medicaid, and others, including insurance paid by work, military, Tricare, someone else,
or other private insurance sources.
9. Marital status was dichotomized as married and others, including unmarried or living
with a partner or parents.
10. Childhood adversity was based on seven questions about maternal childhood
experiences. Total ACE scores were calculated and classified as 0, 1-3, and ≥4. 81

11. The abuse status was assessed by the pre-pregnancy physical/emotional abuse as yes/no
in the PRAMS questionnaire.
12. Depression and anxiety were assessed by the questions about pre-pregnancy health
conditions having depression and anxiety. Depression and anxiety were combined into a
single variable called depression/anxiety.
13. Mental Distress: was assessed by the question about feeling depressed or sad during the
preconception period.
Statistical Analysis
All statistical analyses were conducted in SPSS (IBM SPSS Statistics for Windows,
Version 26.0) 82 using complex survey procedures advised by the Center for Disease Control and
Prevention (CDC).
Specific aim 1(a)
For descriptive analysis, frequencies and weighted percentages with 95% CI were
computed using weights assigned to each observation in the PRAMS dataset. Bivariate analysis
was performed using chi-square statistics for pregnancy intention by substance use and
sociodemographic factors. The binomial logistic regression procedure was used to compute the
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odds of unintended pregnancy for each type of substance use after adjusting for all
sociodemographic factors. For subtypes of unintended pregnancy, i.e., mistimed, unwanted, and
ambivalent multinomial logistic regression procedure was used for each type of substance use
after adjusting sociodemographic factors. Crude and adjusted odds ratios with 95%CI and pvalue were calculated.
Results 1(a)
Sample Characteristics. Of the 74,543 women who participated in PRAMS 2016-17, the
majority were White (69.6%), non-Hispanic (80.3%), and living in urban areas (78.3%). Table 1
provides information about the sample characteristics. The mean age was 23.48±5.8 (range1246) years. More than half (58.9%) of women were between 25-35 years of age. A large
proportion (62.1%) were married. About 12.9% did not complete their high school degree, and
36.2% had obtained a graduate degree. Nearly 14% did not have health insurance, and 27.7%
reported living below the federal poverty level. Almost a half (46%) reported physical or
emotional abuse, while 6.6% of women reported having experienced four or more adverse
childhood experiences. One in six women (17.3%) reported having depression or anxiety.
Pregnancy Characteristics of Sample. More than 40% of pregnancies were reported as
unintended; of those reports, 19.5% were mistimed, 6.2% were unwanted, and 15.3% were
described as ambivalent. Preconception contraception use was reported by 41% of women.
About two-thirds (68.5%) of the sample had adequate prenatal care, 19.1 % mentioned having
intermediate PNC, 5.8% did not have adequate PNC, while for 6.6%, the information on the
adequacy was not available.
Substance Use. OTC pain relief was found to be most commonly used (70%), followed by
alcohol (56.6%). One-third (31.8%) of women reported binge drinking. Seventeen percent
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documented smoking, while 10.6% reported nicotine/tobacco use other than smoking. Cannabis
use was described by 10%, followed by prescription antidepressants (7.1%), prescription opioids
(5.2%), and illicit/recreational drugs (4.2%).
Maternal Substance Use and Unintended Pregnancy. Table 2(a) shows the association of
preconception substance use behavior and pregnancy intention (unintended vs. intended).
Crude and adjusted ORs indicated increased odds of unintended pregnancy with all types of
substance use. Unintended pregnancy was significantly and positively associated with smoking
(AOR: 1.5, 95% CI: 1.4-1.6), with risk estimates highest in those reporting heavy smoking
(AOR: 1.9, 95%CI: 1.5-2.3). The dichotomous measure of preconception alcohol consumption
demonstrated no risk of unintended pregnancy (AOR: 1.05, 95%CI: 1.0-1.1). However, those
documenting heavy drinking were almost twice as likely to report unintended pregnancy (AOR:
1.9, CI: 1.5-2.2) compared to no drinking. Binge drinking was also found to be significantly
associated with unintended pregnancy (AOR:1.2, 95%CI:1.04-1.4). Similarly, the likelihood of
unintended pregnancy was elevated considerably in participants reporting the use of
nicotine/tobacco (AOR: 1.4, 95% CI: 1.3-1.5), cannabis (AOR: 1.9, 95% CI: 1.5-2.3),
illicit/recreational drugs (AOR: 1.7, 95% CI: 1.2-2.4).
Also, the use of specific medications was significantly associated with increased odds of
unintended pregnancy, including prescription opioids (AOR:1.4, 95% CI: 1.02-1.9), and
antidepressants (AOR:1.8, 95% CI: 1.1-3.0).
Maternal Substance Use and Unintended Pregnancy Subtypes. Table 3(a) presents the
distribution of intended and three subtypes of unintended pregnancy, i.e., ambivalent, mistimed,
and unwanted pregnancy with substance use. The prevalence of all three subtypes was higher
with substances including smoking, heavy and binge drinking, nicotine/tobacco, cannabis, illicit
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drugs, and prescription opioids. However, the number of unwanted pregnancies was reduced to
half among participants who documented using prescription antidepressants compared to those
who did not (6.3% to 3.5%). The highest unwanted pregnancy rates were observed with
prescription opioids (12.8%) and illicit/recreational drugs (12.7%). The rates of mistimed were
higher with cannabis use (28.6%).
Tables 4(a) illustrate substance use associations with unintended pregnancy subtypes.
Preconception smoking and use of nicotine/tobacco, cannabis, illicit drugs, and prescription
opioids significantly increased the likelihood of ambivalent, mistimed, or unwanted pregnancies.
AORs for unintended pregnancy subtypes ranged from 1.1 to 2.3, with estimates appearing
highest overall for unwanted pregnancy.
The association between ambivalent (AOR: 1.0, 95%CI: 0.9-1.1) and unwanted
pregnancy (AOR: 0.9, 95%CI: 0.8-1.0) with dichotomous alcohol use and unwanted pregnancy
with prescription antidepressants was not statistically significant (AOR: 0.7, 95%CI: 0.2-1.9).

Statistical analysis (1b)
Four substance-using groups were identified, including alcohol, tobacco/nicotine
(including smoking cigarettes and tobacco and nicotine products), prescription opioids, and illicit
and recreational drugs. Stratified descriptive analysis was performed for the above four
substances to describe and compare their characteristics, yielding frequencies, and weighted
percentages. The classification of the outcome variable and other covariates is explained in the
methods section. The bivariate analysis was performed using Chi-square statistics for each
substance use group by pregnancy intention. Variables not significantly associated (p-value <
.05) with pregnancy intention were excluded from the multivariable analysis. For each substance
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use group, separate models were created for each sociodemographic indicator after adjusting for
potential confounders. Crude and adjusted odds ratios with 95% CI and p-value were calculated.
Results (1b)
Population characteristics. Table 1(b) presents the sample characteristics of the women that
gave live births during 2016-17 and participated in the PRAMS, stratified by the substance use
categories. The total sample consisted of 74,543 women. Among those, 39,831(56.6%) reported
alcohol consumption, 17,535 (22.1%) mentioned tobacco and nicotine products, prescription
opioid use was revealed by 848(5.2%), and illicit and recreational drugs by1889(10.8%) of the
participants. Among all women and four substance-using groups, more than two-thirds of the
women (≈ 78%) resided in urban areas; a majority were non-Hispanic Whites and were between
25-35 years of age. Among alcohol-using women, a larger fraction (45.6%) had a graduate
degree than the other three groups, where more immense proportions had high school or less than
high school. Regarding the socio-economic status, among alcohol using women (19.6%),
tobacco/nicotine (41.6%), prescription opioids (46.4%), and illicit/recreational drugs (53.3%) of
women documented their annual income below the FPL. Among all women (62.1%) and alcohol
users (65.6%), about two-thirds of the participants reported their marital status as married, while
among illicit/recreational drug users, only one-third (31.4%) were married. Almost a double
number of women among illicit/recreational drugs (37.5%) and prescription opioids (38.5%)
users have depression or anxiety compared to all women (17.3%). Overall, about a half of the
women (≈ 46%) reported having physical or emotional abuse before pregnancy, a much high
prevalence was noted among opioid users (68.8%), followed by illicit/recreational drugs users
(58.2%).
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Pregnancy characteristics of the sample. Among all women and alcohol users, about (40%) of
the pregnancies were unintended, while in prescription opioid users (55.8%), tobacco/nicotine
(56.9%), and the highest prevalence was noted among illicit/recreational drug users (65.1%).
Three out of four illicit/recreational drugs users (74.2%), two-thirds of the tobacco/nicotine
(63.3%) users revealed not using any contraception. The adequacy of prenatal care assessed by
the Kessner Index indicated that a more significant fraction of alcohol users had adequate PNC
(73.5%) compared to tobacco/nicotine users (64.5%) and opioids users (63.3%). In comparison,
only a half (55.7%) of illicit/recreational drug-using women had adequate PNC. (Table 1b).
Socio-demographic indicators of unintended pregnancy among substance-using women
Alcohol consumption. Among women who reported alcohol consumption, living in urban areas
(AOR: 1.2, 95%CI: 1.1-1.3), Black race (AOR: 2.1, 95%CI:1.7-2.6), annual income less than
FPL (AOR:2.2, 95%CI: 1.9-2.4), not being married (AOR: 3.2, 95%CI: 2.9 – 3.5), having
depression or anxiety (AOR:1.3, 95%CI:1.2-1.4) were statistically significant predictors of
unintended pregnancy. Maternal age groups less than 35 years of age were also found to have a
higher risk, with the highest magnitude observed among those ≤17 (AOR: 7.0, 95%CI: 1.9-25.3),
and 18-24 years (AOR:2.1, 95%CI: 1.8-2.3) of age. After adjusting with potential confounders,
physical or emotional abuse did not significantly relate to unintended pregnancy (AOR: 0.96,
95%CI: 0.9-1.04). (Table 2b).
Tobacco/nicotine use. Table 3b indicates the association of maternal characteristics with
unintended pregnancy among women using tobacco or nicotine. Elevated risks for unintended
pregnancy were noted with urban living (AOR:1.2, 95%CI:1.02-1.3), Black race (AOR: 1.5,
95%CI: 1.02-2.1), annual income below FPL (AOR:1.9, 95%CI:1.7-2.1), not married (AOR: 2.4,
95%CI: 2.1- 2.7), and having depression or anxiety (AOR:1.1, 95%CI: 1.01-1.3). Maternal age
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≤17 (AOR:5.2, 95%CI: 2.1-12.6), 18-24 years (AOR: 1.8, 95%CI: 1.5-2.2), and 25-35 years
(AOR: 1.2, 95%CI: 1.01-1.4) showed increased risk. Maternal education level <HS (AOR: 1.7,
95%CI: 1.4-2.1), HS only (AOR:2.1, 95%CI:1.7-2.5), and some college (AOR:2.0, 95%CI:1.72.3) indicated a higher likelihood of unintended pregnancy than women having a graduate degree
among women using tobacco/nicotine.
Prescription opioid use. A substantially high risk of unintended pregnancy with opioid use was
noted among women living in urban areas (AOR:3.5, 95%CI: 1.8-6.8) than other substance
users. Contrary to other groups, Hispanic White (AOR: 2.8, 95%CI:1.01-7.7) and other races
(AOR:4.0, 95%CI:1.9-8.5) had increased odds of unintended pregnancy. No significant
association was observed with the maternal age groups 18-24 years (AOR: 1.2, 95%CI:0.4-3.5),
25-35 years (AOR: 0.74, 95%CI: 0.3-1.6), and educational attainment <HS (AOR:1.2,
95%CI:0.3-4.2), HS only (AOR:1.7, 95%CI:0.6-4.7), and some college (AOR: 2.0, 95%CI: 0.85.2). Having income <FPL (AOR: 3.0, 95%CI:1.6-5.7), marital status other than married (AOR:
1.8, 95%CI: 1.01-3.4), and having depression and anxiety (AOR: 2.0, 95%CI: 1.05-3.9) depicted
increased risk for unintended pregnancy with preconception opioid use. (Table 4b).
Illicit and recreational drug use. Table 5b presents the results of the multivariable analysis
conducted to determine the indicators of unintended pregnancy among women using illicit and
recreational drugs during the preconception period. A higher likelihood of unintended pregnancy
was noted among those residing in urban areas (AOR: 2.7, 95%CI:1.7-4.1), others racial group
(AOR: 3.3, 95%CI:1.9-5.8), women aged ≤17 (AOR: 11.3, 95%CI: 1.7-76.2), have some college
education (AOR: 2.3, 95%CI: 1.2-4.4), had annual income <FPL (AOR:2.2, 95%CI: 1.4-3.4),
and had marital status other than married (AOR: 2.4, 95%CI: 1.4-3.9).
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Discussion
Findings (Aim 1a)
Our results of the population-based, representative sample of women of childbearing age
substantiated that preconception substance use is associated with unintended pregnancy. The
three sub-types of unintended pregnancy were also associated with substance use. To the authors'
knowledge, it is the study first examining the distribution of unintended pregnancy and its
subtypes and the relation of preconception substance use to these outcomes in a large national
sample of women.
Many of the associations found in the current study are previously reported in the
literature, such as smoking, illicit drugs, tobacco, and cannabis. 83-84-85 The likelihood of
unintended pregnancy was significantly elevated with heavy smoking, high alcohol consumption,
and binge drinking, similar to what is reported in the literature.73 Analyses by unintended
pregnancy subtype yielded similar results overall, and the magnitude of the associations varied
modestly. However, overall highest risk estimates were observed for unwanted pregnancies.
Lower contraceptives could explain high rates of unintended pregnancy since six in ten
women in the current sample revealed no contraceptive use. It may happen due to perceived low
risk of pregnancy, lack of understanding of the risk of substance-exposed pregnancy, and barriers
to using healthcare services. 86 Women with substance use suffer from poor sexual and
reproductive health. They encounter individual and systemic challenges, including medical and
psychological comorbidities, neglect and abuse, mistrust of healthcare services, guilt, denial, and
embarrassment regarding substance use, fear of losing child custody, and poor access to family
planning services. 87 These high-risk situations indicate the significance of recognizing and
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reducing substance use among women of childbearing age and facilitating effective
contraceptive use among women tending to avoid pregnancy.
About half (46%) of the women reported physical or emotional abuse in the current
study. An abusive relationship and environment of fear may limit women’s control of their
fertility, leading to unintended pregnancy.28 The physical and mental health consequences of
abuse are known. Having an abusive relationship or a traumatic past is also associated with
higher odds of substance use. 88 Thus screening and identifying women with a history of physical
and emotional abuse is crucial for implementing best practices known to improve survivor’s
outcomes. 89
Findings (Aim 1b)
Our findings from a large representative sample of the US women of childbearing age
revealed that around a half of the women were consuming alcohol, 1 in five were using tobacco
or nicotine products, about 5% were using prescription opioids, and 1 in ten were using illicit or
recreational drugs during the preconception period. The results of the multivariable analysis
indicated a higher risk of unintended pregnancy among substance-using women who were living
in urban areas, were ≤17 of age, did not have a graduate education, had an annual income less
than FPL, were not married, and had depression or anxiety during the preconception period. The
magnitude of risk varied among racial and ethnic groups. The likelihood of unintended
pregnancy was significantly higher among Black women using alcohol, tobacco/nicotine, opioid
using non-Hispanic Whites, and illicit/recreational drugs using women from other races. To the
authors’ knowledge, this is the first study investigating the sociodemographic indicators of
unintended pregnancy among various substance-using groups in a representative sample of US
women.
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The prevalence of alcohol, tobacco/nicotine products, and illicit/recreational drugs noted
in the current sample are similar to what is reported in another national sample of US women.33
However, a slightly higher prevalence of non-medical opioid use was reported by the NSDUH
sample of women of childbearing age.53
Among all substance-using groups, illicit and recreational drug users noted a
considerably high prevalence of unintended pregnancy. In literature, other population-based
studies have also reported similar findings. 90 This suggests that illicit and recreational drugs are
an essential risk factor for poor reproductive and sexual health among women of childbearing
age and requires a comprehensive approach to address the issue.
One of the strongest predictors of unintended pregnancy among all substance-using
groups was urban living. Urban living women using prescription opioids were three times more
at risk of unintended pregnancy than women in rural areas. In contrast, a twofold risk was
observed among illicit and recreational drug users. This aligns with a study's findings conducted
in New York City, where illegal use of drugs was significantly associated with unintended
pregnancy. 91 Although rural populations had a higher proportion of adolescent pregnancies. 92
The higher prevalence of substance use among urban populations may lead to poor reproductive
health, leading to unintended pregnancies among urban women. 93-94
Poor socioeconomic status is a well-known risk factor for poor sexual and reproductive
health, leading to unintended pregnancy.23 In the present study, we also found that having an
annual income less than FPL was a strong predictor of unintended pregnancy among all
substance users, specifically among prescription opioid users, who were three times more likely
to report unintended pregnancies. These findings are consistent with the existing literature
showing that less annual income than FPL was independently associated with pregnancy
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intention. 95 It is also reported that women below FPL were five times more likely to experience
an unintended pregnancy.1 A study conducted among urban poor women revealed that the
majority of women did not have access to effective contraception and family planning services.91
In our findings risk of unintended pregnancy tend to decrease with maternal age. Among
all substance users, age < 17 was a significant predictor of unintended pregnancy compared to
the women aged 35 years and above. These findings are consistent with the existing literature. 96
The proportion of unintended pregnancy tends to decrease with age, and the adolescents aged 1519 had the highest rates of unintended pregnancy than any other age group. 97 Furthermore,
educational attainment less than graduate-level was also found to increase unintended pregnancy
among all substance-using women. Another study aimed to determine the risk factors of
unintended pregnancy among substance-using women reported similar findings.16
Another significant factor associated with an unintended pregnancy is marital status. The
current study's findings revealed 2-3 folds increased risk of unintended pregnancy among women
whose marital status was others. Unintended pregnancy was found to be highly correlated with
marital status, where unmarried women were five times more likely to experience them. 98 A
national study found a higher rate of unintended births among cohabiting women (141 per 1,000)
than married women (33 per 1,000).1 Having depression or anxiety during the preconception
period also emerged as a determinant of unintended pregnancy among women using substances.
Past studies have shown that women with poor mental health were more likely to use substances
and experience poor sexual and reproductive health. 99-100
Women from racial and ethnic minorities are at increased risk of experiencing an
unintended pregnancy. 101 Our study found an increased risk among Black women using alcohol
and tobacco/nicotine, opioids using non-Hispanic Whites, and illicit/recreational drugs using
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women from other races. Various social and economic factors contribute to health disparities. A
study based on National Survey of Family Growth data reported age, relationship status, annual
income, education, and insurance contributing factors to the higher likelihood of unintended
pregnancy.20
The women using substances before or during pregnancy are also likely to have
inadequate PNC. 102 In current findings, substance-using women reported inadequate PNC;
specifically, about a half of women using illicit and recreational drugs had inadequate PNC. The
women who do not have adequate PNC are at higher risk of preterm birth, low birth weight, and
other adverse outcomes. 103

Public health implications
Given the high prevalence of substance use and the risk of unintended pregnancy among
women of childbearing age, it is essential to identify and educate them for healthy decisionmaking. Brief culturally sensitive interventions are recommended in primary care, obstetrics and
gynecologic, and family planning services. 104 The findings of our study also provide a deeper
insight into the factors contributing to the poor reproductive health among all and specifical
women with substance use. It is essential to identify the women at higher risk and ensure that
younger women, minorities, and women with poor socioeconomic status have information and
access to reproductive and family planning services. 105 The current study's findings also have
serious implications for providing adequate PNC among substance-using women, specifically
women using illicit substances, for improving birth outcomes. 106 Providers must be aware of the
women's unique needs and implications surrounding substance use.38 To identify the women at
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risk, educate them and provide treatment and family planning services, there is a need for
evidence-based, integrated, clinical, and behavioral interventions.88

Strengths and Limitations
The current study utilized data from a large, population-based, representative sample of
women with detailed information on a wide range of potential confounders, pregnancy intention,
sub-types, and the range of substances used. The study used a granular approach and provided
insight into a range of social demographic, and economic risk factors of unintended pregnancy
among various substance-using women.
Despite the strengths, the study has a few limitations that should be considered while
interpreting the study's findings. First, the analysis is limited to women giving live births, leading
to underreporting adverse outcomes (miscarriage or stillbirth) associated with unintended
pregnancy and substance use. Additionally, nearly half of unwanted pregnancies end up in
abortion.1 Relation between abortion and prior substance use is also documented in the literature;
our study did not have this information. Secondly, due to retrospective measurement, recall bias
may influence pregnancy intention. However, studies on the reliability of pregnancy
intendedness conducted a detailed analysis of the National Longitudinal Study of Youth 107,
National Longitudinal Study of Adolescents Health 108, and National Survey of Family
Growth. 109 They found aggregate levels estimated relatively stable across repeated
measurements with small inconsistent reports in both directions. Third, PRAMS questionnaires
are self-reported and may be subjected to under-reporting of behaviors perceived to be
unhealthy. Substance use is prone to underreporting owing to social desirability bias and the
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stigma of illicit drug use. However, women may be more willing to disclose their behaviors on a
confidential survey as PRAMS data than other sources. 110

Conclusion
Substance use is known to have detrimental effects on maternal and child health. After
accounting for several maternal characteristics, the findings from this large population-based
sample of US women indicated that substance use was significantly and positively associated
with unintended pregnancy. This study also determined the indicators of unintended pregnancy
among different substance users. We found strong evidence that maternal age <17, living in
urban areas, not having a graduate degree, annual income <FPL, and not being married increased
all substance users' risk of unintended pregnancy. Having depression and anxiety before
pregnancy was associated with unintended pregnancy among alcohol, nicotine and tobacco, and
prescription opioid users. This study's findings underscore the importance of recognizing and
addressing preconception substance use among women of childbearing age, counseling, and
provision of effective contraception methods to reduce unintended pregnancy and associated
adverse effects on maternal and child health.
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Chapter 3
Polysubstance Use and Risk of Unintended Pregnancy
Abstract
Background: Polysubstance use among women of childbearing age poses serious risks to
maternal and child health. However, information regarding the relation between polysubstance
use and unintended pregnancy in this population is limited. To address this gap, we investigated
the prevalence and patterns of polysubstance use in a population-based sample of reproductiveaged US women, assessed the association of specific polysubstance use patterns to the risk of
unintended pregnancy, and examined the relation of sociodemographic factors to unintended
pregnancy in women co-using alcohol and other substances.
Methods: In this cross-sectional study, we used data from the Pregnancy Risk Assessment
Monitoring System (PRAMS) representing 39 states and New York City. The sample comprised
74,543 women giving live births and participating in PRAMS 2016-17. Stratified descriptive
analyses were used to compare women's characteristics with polysubstance use. Binary and
multinomial logistic regression analyses were used to estimate the risk of unintended pregnancy,
its subtypes (unwanted, mistimed, and ambivalent), and sociodemographic correlates of
unintended pregnancy in participants reporting alcohol use (n=39,831). All multivariable
analyses were adjusted for demographics, rurality, and other potential confounders.
Results: Prevalence of polysubstance use was high in the current sample. Among alcohol users
(21.5%) were also smoking cigarettes, and (13%) were using cannabis. Similarly, among
cigarette smokers, about two-thirds (70%) were also consuming alcohol, 50% were heavy, or
binge drinkers and one-fourth (25%) were using cannabis. Larger fractions of women reporting
heavy drinking and heavy smoking reported co-using other substances. Relative to the alcohol
use, only the likelihood of unintended pregnancy was significantly elevated in women co-using
alcohol with heavy smoking (AOR: 1.5, 95%CI:1.4 – 1.6), cannabis (AOR: 2.0, 95%CI:1.6 –
2.4), tobacco/nicotine (AOR: 1.6, 95%CI:1.4 – 1.7), and illicit/recreational drugs (AOR: 1.8,
95%CI: 1.1 – 2.7). Odds of unintended pregnancy were particularly high among heavy or binge
drinkers who smoked cigarettes (AOR: 1.9, 95%CI: 1.5 – 2.4), used cannabis (AOR: 2.1,
95%CI: 1.4 – 3.1), or consumed other tobacco/nicotine products (AOR: 2.3, 95%CI: 1.7 – 3.1).
Analysis by unintended pregnancy subtype yielded similar findings overall, with unwanted
pregnancy showing the strongest association ranging from an AOR = 1.8 (95%CI: 1.5 - 2.1) with
smoking and alcohol to an AOR = 4.7 (95%CI: 2.7 – 8.2) with co-using alcohol with illicit
drugs. Living in urban areas and income below FPL were significant predictors of unintended
pregnancy among all groups of polysubstance use.
Conclusion: In this large sample of reproductive-aged US women, polysubstance use during the
preconception period was positively and significantly associated with increased odds of
unintended pregnancy. Urban residence, low education, poverty, and having depressive
symptoms prior to conception were significant correlates of unintended pregnancy among
women co-using substances. The findings of this study may aid in identifying women at risk of
poor reproductive health when developing tailored and culturally sensitive screening and
treatment interventions to improve maternal and child health outcomes.
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Introduction
Polysubstance use is defined as using more than one substance used simultaneously or
within a period. 111 It refers to the co-use of substances, including but not limited to heavy or
binge drinking of alcohol, nicotine, cannabis, medical and non-medical use of prescription
medications, stimulants (cocaine), opioids (heroin), and hallucinogens. 112
Despite the high prevalence of substance use among women of childbearing age, 113
limited literature is published on polysubstance use. A study that used pooled data (2005-2014)
from National Survey on Drug Use and Health (NSDUH) on reproductive-aged women in the
United States (US) found polysubstance use common among respondents. 114 They found that
about 50% of women who used prescription opioids for non-medical reasons were binge
drinking.113 Another NSDUH study using 2015-18 data to investigate alcohol use and co-use of
other substances among women of childbearing age found that 38.2% of pregnant respondents
who indicated consuming alcohol also reported using one or more additional substances.112 These
substances included tobacco (28.1%), marijuana (20.6%), opioids, and other substances. The
women who continued use during pregnancy also reported substance use in the preconception
period.112 Another study documented co-using opioids with smoking cigarettes during
pregnancy. 115 The findings from eight US states' data noted that about two-thirds of women
using cannabis before and during pregnancy also smoked cigarettes. 116 Substance use is also
associated with increased odds of unprotected sex, prior abortion, sexually transmitted infections
(STI) symptoms, 116, and a higher risk of developing comorbid health and psychiatric
conditions. 117 A recent study based on PRAMS data from 6 US states reported the prevalence of
preconception marijuana of 8%. Among these users, 55% also smoked tobacco, and 77.4%
consumed alcohol. 118 Only a few studies have documented polysubstance use among women of
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childbearing age, and lesser is known about their reproductive health. A higher prevalence of
polysubstance use was observed among non-Hispanic Whites and women with low educational
attainment.114 The paucity of studies on polysubstance use among women points to the gap in the
literature.
Treatment and prevention strategies for polysubstance use are limited compared to single
substance use. 119 In addition, women with polysubstance use suffer poor reproductive and sexual
health 114 and are likely at increased risk for unintended pregnancy. 120 The prevalence, patterns,
and sociodemographic correlates of polysubstance use among women merit additional
investigation. This information could help identify at-risk women and guide the prevention and
treatment efforts to improve maternal and child health outcomes. To address this gap, the current
cross-sectional study assessed the prevalence and patterns of polysubstance use, the likelihood of
unintended pregnancy associated with polysubstance use, and the sociodemographic correlates of
unintended pregnancy among women with polysubstance use in a national representative sample.
Specific aim 2
Specific Aim 2a: Examine the association of polysubstance use and unintended pregnancy
among women of childbearing age. If analyses indicate a significant association, compare
polysubstance use between sub-types of unintended pregnancies: 1) mistimed, 2) unwanted and
3) ambivalent.
Aim 2b: Assess the association between sociodemographic correlates and unintended
pregnancies among women with polysubstance use.
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Materials and Methods
Data and measures
The current study is based on a cross-sectional, secondary data analysis of a subset of the
PRAMS Phase 8 data. For a complete description, refer to Chapter 2.
Outcome Variables:
Pregnancy Intention. The outcome variable pregnancy intention was assessed by
response to the following question, "Thinking back to just before you got pregnant, how did you
feel about getting pregnant? The responses, "I wanted to be pregnant then" or "I wanted to be
pregnant sooner," were classified as intended pregnancies. The response "I wanted to be pregnant
later" was regarded as mistimed, and "I did not want to be pregnant then or in the future" was
classified as unwanted. The response, "I was not sure," was categorized as ambivalent. Mistimed,
ambivalent, and unwanted were grouped as unintended pregnancies for binary analysis. 121
Exposure variables: Substance use included the following substances.
Alcohol consumption: For alcohol consumption, those who responded yes to drinking were
categorized as drinkers. The number of alcoholic drinks /weeks was used to define moderate (up
to 7 drinks/week) and heavy drinking (8-14 drinks/week). 122 Binge drinking was described as
having four or more drinks in 2 hours, at least once during the preconception period. 123
Cigarette smoking: Preconception smoking was assessed by a yes/no question about smoking
three months before pregnancy. Smoking levels were built on the number of cigarettes/ days, <10
cigarettes/day were considered moderate smoking, and≥ 10 were regarded as heavy
smoking. 124,125
Cannabis: Cannabis use was assessed by one- and three-month usage before pregnancy.
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Opioids (Prescription) were defined as hydrocodone (Vicodin), oxycodone (Percocet), or
codeine.
Illicit/ recreational drugs: The variable illicit/recreational drugs was created by combining the
yes/no questions about the following drugs: 1- adderall, 2-methadone, 3-heroin, 4amphetamines, 5- cocaine, 6- tranquilizers, and 8- sniffing gasoline, glue, aerosol spray cans, or
huffing
Nicotine/Tobacco products other than smoking: Due to the small number of respondents
(ranging from 0.7%-6.6%), new variable nicotine/tobacco forms were created by combining the
use of hookah, electronic cigarettes, cigars, cigarillos, flavored cigars, nicotine, betel nut or betel
quid, and chewing tobacco, snuff, snus, and dip.
Polysubstance was defined as using two or more of the above substances by the participants.
Covariates: The covariates included maternal age, race/ethnicity, education, rurality,
income to needs ratio, and having mental distress. Rural/urban status was assigned using
National Center of Health Statistics (NCHS) codes. Maternal age at conception was categorized
as ≤17, 18-24, 25-34, and 35+years. The race was classified as Asian, White, Black, and others.
Education was based on years of education as less than high school (<12years), high school
(12years), some college (13-15years), and graduate (≥16). The income-to-needs ratio was
derived from family income (median of the income categories) and family size (number of
dependents plus self) variables. The poverty threshold adjusted for a family was divided by
annual household income size using the Census Bureau's guidelines to determine the poverty
threshold adjusted for family size (2016-17, respectively). 126 The variable was dichotomized as
<1 below the federal poverty level (FPL) and ≥1as at/above FPL. 127 The question about feeling
sad or depressed before the current pregnancy defined mental distress.
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Due to the smaller number of participants in a few polysubstance using groups, age,
education, and race/ethnicity were recategorized for the sociodemographic indicators.
Participants were categorized as ≤19, 20-34, and 35+ years of age. Maternal education was
classified as ≤ high school, some college, and graduate. Due to a few respondents in the Asian
category of race and ethnicity, this group was merged with the ‘other’ race category. The
race/ethnicity categories included Non-Hispanic White, Hispanic White, Black, and Others. A
detailed description of the above variables is mentioned in chapter 2.
Statistical Analysis
All statistical analysis was conducted in SPSS version 26 (IBM corp. Armonk NY) using
complex survey procedures advised by the Center for Disease Control and Prevention (CDC). 128
For the descriptive analyses, frequencies and weighted percentages with 95% confidence interval
(CI) were computed using weights assigned to each observation in the PRAMS dataset.
Specific aim 2(a)
Bivariate analysis was performed using chi-square statistics to identify the polysubstance
use patterns. Binary and multinomial logistic regression were used to assess the independent
association of unintended pregnancy overall and by subtype (unwanted, mistimed, and
ambivalent) to polysubstance use (smoking, alcohol consumption, and use of marijuana,
illicit/recreational drugs, and prescription opioids). Multivariable analyses were adjusted for
demographics, rurality, and other potential confounders.
Specific aim 2(b)
Descriptive analyses were performed to study and compare the sociodemographic
characteristics of women co-using alcohol with other substances, yielding frequencies and
weighted percentages. We identified three highly prevalent patterns of substance use involving
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alcohol, including use of alcohol only, alcohol use in concert with cigarette smoking, use of
alcohol with cannabis, and use of alcohol in addition to illicit/recreational drugs. To assess the
relation of sociodemographic characters to unintended pregnancy among these groups of
substance users, we created individual models for each sociodemographic variable. These factors
include maternal age, race/ethnicity, level of education, annual income, marital status, and
rurality.

Results
Sample characteristics
Of the 74,543 women of childbearing age who participated in the PRAMS 2016-17
survey, 39831 (56.6%) consumed alcohol, with one-third (33%) being involved in binge or
heavy drinking. The prevalence of cigarette smoking was 17.4%, and nearly one in four (27%)
smokers reported heavy smoking during the preconception period. Table 1 shows participants’
sociodemographic characteristics stratified by smoking and alcohol use. The majority of the
women were located in urban areas (~ 80%), were non-Hispanic White, and were 25-35 years of
age. Overall, 62.1% of the women were married, and among the smokers (36.4%) and heavy
smokers (33%), one-third were married. Overall, 72.3% of women reported their income to need
ratio at/above FPL, and the prevalence was higher for those who consumed alcohol (80.4%) than
smoking cigarettes (55%). Also, a smaller proportion of smokers (12.8%) and heavy smokers
(6.5%) had a graduate degree compared to women who drank alcohol (45.6%). Among all
respondents, the prevalence of depressive symptoms (63.4%) and physical or emotional abuse
(57%) were highest among heavy smokers. The inadequacy of prenatal care was noted among
substance-using women; a higher proportion of women smoking cigarettes (8.2%) and heavy
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smokers (8.5%) reported inadequate prenatal care compared to all women (5.8%). The rate of
unintended pregnancies was 41% in the overall population and highest in the heavy smokers
(62.5%), followed by smokers (58%), heavy/ binge drinkers (45%), and alcohol consumers
(39%). Similarly, contraception use was lower in women smoking cigarettes (30%) than alcoholconsuming (41.3%). The breakdown of unintended pregnancy among subtypes, i.e., mistimed,
unwanted, and ambivalent, showed that mistimed pregnancies (23.9%) and unwanted
pregnancies (10.1%) were highest among smokers. In comparison, ambivalent was highest
among heavy smokers (27.9%) compared to all other groups.
Polysubstance use
Alcohol was the most commonly used substance, with nearly half of the sample (56.6%)
reported drinking and (33%) heavy or binge drinking. About 17% reported smoking, with 30%
documenting heavy smoking. A higher prevalence of polysubstance use was noted in the current
sample. Among women who mentioned heavy or binge drinking, one-third (31%) smoked
cigarettes, 30% were co-using cannabis, 19.5% used tobacco/nicotine products other than
smoking cigarettes, and 4.5% used illicit/recreational drugs. Polysubstance use was also common
among cigarette-smoking women, two-thirds (70%) consumed alcohol, and a half (50%) were
heavy or binge drinkers. Cannabis use (25.8%), illicit/recreational drugs (12.5%), other
tobacco/nicotine products (33%), and opioids (10.4%) were also reported among smokers. The
co-use of cannabis (31.8%), tobacco/nicotine products (37%), and opioids (13.6%) were highest
among heavy smokers than all other groups (Table 1).
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Association of unintended pregnancy with polysubstance use
Alcohol and heavy or binge drinking
Table 2 depicts the association of unintended pregnancy to co-using alcohol with other
substances in a representative sample of US women. Statistically significant and positive
association of unintended pregnancy was observed with heavy smoking (AOR: 1.5, 95%CI:1.4 –
1.6), cannabis (AOR: 2.0, 95%CI:1.6 – 2.4), tobacco/nicotine (AOR: 1.6, 95%CI:1.4 – 1.7), and
illicit/recreational drugs (AOR: 1.8, 95%CI: 1.1 – 2.7). Higher odds of unintended pregnancy
were noted among heavy or binge drinkers with smoking (AOR: 1.9, 95%CI: 1.5 – 2.4), cannabis
use (AOR: 2.1, 95%CI: 1.4 – 3.1), tobacco/nicotine (AOR: 2.3, 95%CI: 1.7 – 3.1). The risk of
unintended pregnancy was not statistically significant with co-use of opioids with alcohol (AOR:
1.3, 95%CI: 0.9 – 1.9) and heavy or binge drinking (AOR: 1.4: 95%CI: 0.6 – 3.6) after adjusting
for potential confounders.
Association of mistimed, unwanted, and ambivalent pregnancies with polysubstance use
Table 3 shows the likelihood of unintended pregnancy sub-types, i.e., mistimed,
unwanted, and ambivalent with preconception use of alcohol in concert with other substances.
The risk estimates with polysubstance use among alcohol-consuming women varied between
smoking (AOR: 1.3, 95%CI: 1.1 – 1.4) and illicit/recreational drugs (AOR: 2.7, 95%CI: 1.4 –
5.1). Among three sub-types, the magnitude of the association was higher for unwanted
pregnancy with smoking (AOR: 1.8, 95%CI: 1.5 – 2.1), heavy smoking (AOR: 2.3, 95%CI: 1.4 –
3.9), cannabis (AOR: 2.8, 95%CI: 2.0 – 3.8), tobacco/nicotine use (AOR: 1.8: 95%CI: 1.5 – 2.3),
illicit/recreational drugs (AOR: 2.7, 95%CI: 1.4 – 5.1) and opioids (AOR: 2.3, 95%CI: 1.3 –
4.0). The association of mistimed pregnancy with illicit/recreational drugs (AOR: 1.6, 95%CI:
1.0 – 2.6) and opioids (AOR: 1.2, 95%CI: 0.7 – 2.0) were not statistically significant (Table 4).
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Socio-demographic indicators of unintended pregnancy among polysubstance users
In the current sample of US women who gave birth during 2016-17 and participated in
PRAMS 2016-17, about a half (N=39,831) documented alcohol consumption in the
preconception period. To identify and compare the sociodemographic characteristics of women
who were co-using alcohol with other substances following groups were created; alcohol and
smoking (N=9,145), alcohol and cannabis (N=1511), alcohol and illicit/recreational drugs
(N=346), and smoking and cannabis (N=1091). Table 4 shows the maternal characteristics
stratified by the polysubstance use patterns. A larger fraction of women co-using alcohol and
illicit recreational drugs were located in urban areas (86.5%). The majority of women in all
groups were 25-34 years of age, were non-Hispanic White, and had less than high school
education. More women in the alcohol and cannabis group had graduate education (23.7%) than
in other groups. More respondents in smoking and cannabis (55.4%) and alcohol and
illicit/recreational drug (46.0%) users were below the FPL. Two-thirds (65.6%) of alcohol
consumers reported their marital status as married, while a higher proportion of polysubstance
users reported it as other. About half to two-thirds (69.3%) of the pregnancies were reported
unintended in all polysubstance using groups. (Table 4).
Factors associated with unintended pregnancy among polysubstance users
After adjusting with other risk factors, living in urban areas, income below FPL, and
marital status other than married were strong and significant predictors of unintended pregnancy
among all polysubstance users. Women older than 35 years (AOR: 2.0, 95%CI: 1.3 – 3.0) and
Black race (AOR: 1.4,95%CI: 1.1 – 1.7) increased the odds of unintended pregnancy among
women co-using alcohol and smoking. (Table5). Having less than or equal to a high school
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diploma was significantly associated with unintended pregnancy among alcohol and smoking
(AOR: 2.8, 95%CI: 2.3 – 3.6) and alcohol and cannabis users (AOR: 2.6, 95%CI: 1.6 – 4.6).
Women reporting marital status other than married had higher odds of unintended pregnancy
among alcohol only (AOR: 3.2, 95%CI: 3.0 -3.5), alcohol and smoking (AOR: 2.4, 95%CI: 2.0 2.8), and alcohol and cannabis (AOR: 2.8, 95%CI: 1.8 – 4.4).

Discussion
Principal findings
Our findings from the current population-based representative sample of US women
delivering live births during 2016-17 demonstrated a positive and statistically significant
association between polysubstance use during the preconception period and the risk of
unintended pregnancy. The prevalence of unintended pregnancy was 39% for alcohol consumers
and the highest for heavy smokers (62.5%). However, when alcohol was used with smoking,
illicit substances, or cannabis, the prevalence of unintended pregnancy in these sub-groups was
nearly 60%. The analysis by the sub-types also yielded similar results, with higher odds observed
for unwanted pregnancies. We observed a high prevalence of polysubstance use, and women
drinking alcohol also smoked and co-used cannabis, illicit/recreational drugs, nicotine/tobacco,
and opioids. Cannabis was the most commonly co-used substance both with smoking and
alcohol. Compared to moderate drinking and smoking, women with heavy/binge drinking and
heavy smoking had a high prevalence of polysubstance use.
The finding that co-using alcohol with other substances increased the odds of unintended
pregnancy is previously reported. One study found alcohol use/abuse indicative of concurrent
use of the illegal substance and risky sexual behavior, including not using contraception, among
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adolescents and young women aged 18-29 years. 129 Another study noted a high prevalence of
alcohol, tobacco, and cannabis among women of childbearing age, with the most frequent co-use
pattern including alcohol, cannabis, and tobacco. 130 A similar polysubstance use pattern was
observed in the present sample of women of childbearing age. In the current study, the
association of co-using alcohol was not statistically significant with unintended pregnancy after
adjusting for potential confounders, which contradicts the findings of Hail et al., where a high
prevalence of unintended pregnancy was reported among opioid users. This shows the critical
role of socioeconomic factors when examining this association in this study population.
In this study, the authors also performed a stratified analysis of demographic factors by
most prevalent substance use pattern to compare the demographic indicators of unintended
pregnancy. The results showed that most women reporting polysubstance use resided in urban
areas, were 20-34 years of age, were non-Hispanic White, had education ≤ high school, were not
married, and their annual income was below the FPL. About two-thirds of the pregnancies
among participants documenting polysubstance use were unintended. The multivariable analysis
indicated that income less than FPL, living in urban areas, and not having a graduate degree were
substantial and statistically significant predictors of unintended pregnancy. A study conducted in
New York City that focused on the low-income urban population found an even higher
prevalence (>80%) of unintended pregnancy in women who smoked, used drugs, and consumed
alcohol compared to our study. They also found that alcohol consumption increased the odds of
unintended pregnancies among low-income urban women. 131
A precarious finding from our study was the reported depressive symptoms by a large
proportion of the respondents. About 17% of women felt depressed in the preconception period,
and among heavy alcohol users and smokers, the depression rate was more than 50%. This
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alarmingly high prevalence of depression rate needs to be further examined since it is known to
cause poor birth outcomes, including pre-term birth and LBW. 132In the current study, more
women in the substance-using groups reported inadequacy of prenatal care. This is consistent
with what is found in the literature, where women using substances are at an increased risk of
inadequate prenatal care. 133-134.
The findings of our study suggest a potential sequel that starts with the initiation of
substance use with the legal substances, particularly smoking and alcohol, and progressing
towards heavy smoking/drinking and proceeding to co-using other substances. This pattern is in
alignment with the gateway drug hypothesis. This hypothesis suggests the beginning of
substance use with alcohol, tobacco, and cannabis that escalates to using more addictive
substances, including illicit drugs. 135,136
The high prevalence of co-using cannabis with alcohol and smoking is notable
concerning the policy changes and legalization efforts regarding cannabis use in a few states. A
recently published study that used PRAMS 2016 data found higher use of cannabis among states
that legalized its use. It occurs due to the general population’s easy availability and acceptance of
use among the general population.118
Public health implications
The preconception period is a critical time in women’s life to promote healthy behavior
that can significantly improve maternal and child health outcomes. 137 Implementing
interventions to encourage healthy behaviors, including contraception use, screening women for
substance use, and educating them on the harmful effects of substance use, can significantly
improve maternal and child health outcomes.

43

Shafique Dissertation

Polysubstance use among women of childbearing age is common and leads to health risks
for both maternal and child health. Our study’s findings suggest the need for interventions
addressing polysubstance use in women of childbearing age. The United States Preventive
Services Task Force (USPSTF) 138, CDC 139, and American College of Obstetricians and
Gynecologists (ACOG) 140 recommend universal screening of women of childbearing age and
pregnant women. There is evidence suggesting the benefits of screening and concise
interventions leading to a reduction in alcohol use, smoking, and illicit drug use 141,142,143.
In addition to the screening, counseling and treatment services should be offered or
referred. Women with substance use who are not ready to quit or not planning to become
pregnant should be given access to effective contraception methods. Addiction or substance use
is a mental health issue and should be treated like other medical conditions. One of the barriers to
accessing health care and family planning services is the social stigma of substance use. 144
Women with substance use experience social and structural stigma. 145 Education programs for
the general population and healthcare providers to enhance non-stigmatizing behavior can help
people cross these barriers.
The findings of this study also highlighted the increased odds of unintended pregnancy
among urban and women below the FPL. This suggests implementing tailored interventions to
address the needs of women at high risk for unintended pregnancy.
Overall, there is a need for appropriate educational, screening and treatment efforts to
identify the women in need and provide treatment services integrated with family planning
services. 146 When planning and implementing interventions, substance use prevention and
treatment efforts should consider the critical determinants, including social, economic,
environmental factors, social support, family structure, and cultural norms. 147 Screening and
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assessment help provide information regarding these factors and information on mental health, 148
physical or emotional abuse, 149 childhood adversity 150 that are known determinants of substance
use, and poor reproductive health among women. Screening and assessment from a perspective
affirming the cultural values and beliefs facilitate the women's engagement in the screening
leading to the treatment process. 151 In addition to cultural differences, women from minorities,
racial/ethnic groups, living in rural areas, 152 and not speaking English experience unique
challenges while pursuing substance use treatment. 153 A customized supportive therapy aimed to
address the barriers identified in the screening and assessment process may help women contact
and stay in the treatment services. 154
Women with substance use are at an increased risk of unintended pregnancy. An
estimated nine out of ten opioid-using women 155 and eight out of ten pregnancies among illicit
drug-using women131 were unintended. Inconsistent or a complete lack of effective
contraception is one of the significant correlates of unintended pregnancy. 156 Women using
substances report poor or no access to family planning services, even when they are in treatment
services or after discharge. 157-158 The most commonly reported barriers to family planning
services include but are not limited to fear of criminalization, feeling of guilt and shame, lack of
information, lack of insurance, difficulty getting appointments, and filling birth control
prescriptions. 159 A systematic review on preventing unintended pregnancies among substanceusing women found contraception counseling and provision more effective than traditional
educational methods. 160 Another systematic review concluded that offering contraception
services and substance use treatment could help reduce unintended pregnancy among these
women. 161 A qualitative study conducting in-depth interviews and focus groups with 115 women
found that most women prefer family planning services conjugated with substance use
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treatment. 162 Thus, efficient screening followed by customized evidence-based interventions may
help address substance-using women's reproductive needs.
Strengths and limitations of the study
To the best of our knowledge, this is the first study examining the association between
polysubstance use and unintended pregnancy among women of childbearing age in the US. This
study used a large sample from population-based data of PRAMS. We also performed a stratified
analysis to compare the characteristics of groups with highly prevalent patterns of co-using
substances. The study also identified a range of predictors of unintended pregnancy women
reporting polysubstance use.
The study also has a few limitations. First, this cross-sectional study cannot predict
polysubstance use patterns over time. However, estimating preconception substance use might
provide a temporal relationship to measure the risk associated with unintended pregnancy.
Secondly, the analysis was limited to women with live births, potentially leading to
underreporting adverse outcomes (miscarriage or stillbirth) related to unintended pregnancy and
substance use. Additionally, nearly half of unwanted pregnancies end up in abortion. 163
Association between abortion and prior substance use has also been documented in the literature;
our study did not have this information. Third, due to retrospective measurement, recall bias may
influence pregnancy intention. However, detailed analyses regarding the reliability of selfreported pregnancy intendedness have been conducted using data from the National Longitudinal
Study of Youth, 164 National Longitudinal Study of Adolescents Health, 165 and National Survey
of Family Growth 166 indicate that, in aggregate, prevalence estimates remain relatively stable
across repeated measurements with small inconsistent reports in both directions. Fourth, PRAMS
questionnaires rely on self-report and may thus under-ascertain behaviors perceived as
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unhealthy. Polysubstance use is prone to underreporting owing to social desirability bias and the
widespread stigma of illicit drug use. 167 However, women may be more willing to disclose their
behaviors on a confidential survey such as PRAMS than via other venues. 168 Fifth, Since
PRAMS data only include women with a fixed address, this study did not include homeless or
transient women.

Conclusion
In the current sample, the US women of childbearing age reporting polysubstance use
during the preconception period were more likely to experience an unintended pregnancy. They
were also likely to live in urban areas, not have a graduate-level education, not be married, and
have less annual income than FPL. These factors should be considered in developing and
implementing tailored screening and treatment interventions to prevent unintended pregnancy
among women using substances to improve maternal and child health outcomes.
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Chapter 4

Unintended Pregnancy Among Substance-Using Women: A Systematic Review with
Meta-Analysis
Abstract
Background: Unintended pregnancy is an indicator of reproductive health and has severe
consequences for women's and children's health and wellbeing. Although unintended pregnancy
rates are higher among women who use illicit and recreational drugs, systematic reviews are
lacking to estimate the pooled risk of unintended pregnancy in this population. In this study, we
conducted a systematic review (SR) with meta-analysis (MA) to address this gap.
Methods: Predetermined criteria were used to determine study eligibility. To identify studies, we
screened records from six electronic databases (PubMed (MEDLINE), Scopus, CINAHL,
PsychINFO, and Web of Science) and reviewed citations from retrieved articles. Data from
included studies were abstracted in a pretested codebook. Each study was assessed for risk of
bias using the Newcastle-Ottawa Scale (NOS). The pooled effect size was calculated using the
inverse variance method. Heterogeneity among studies was determined using I2 statistics. A DOI
plot with an LFK index was created to assess the risk of publication bias. In addition, we
compared the prevalence of illicit and recreational drug use, unintended pregnancies, and its
determinants across studies. Influence analysis was used to evaluate the robustness of pooled
findings.
Results: Eight studies (1 case-control, 1 cohort, 6 cross-sectional) met criteria for inclusion in
our review (N=38,520 women). Prevalence of reported illicit and recreational drug use ranged
from 4.0-21.0%, and that of unintended pregnancy, from 5.3 - 82.0%. Pooled findings of our
meta-analysis indicated that the use of illicit and recreational drugs during the preconception
period was significantly and positively associated with the likelihood of unintended pregnancy
(pooled odds ratio (POR)=1.84, 95% confidence interval 1.4-2.4). Influence analysis supported
the robustness of these findings, with PORs ranging from 1.65 – 2.1, and all remaining
significant. The DOI plot was asymmetrical, and the LFK index was 2.66 suggesting a potential
small study effect. NOS scores indicated a moderate to low risk of bias across studies.
Conclusion: The findings of this SR with MA suggest that maternal preconceptual use of illicit
and recreational drugs may substantially increase the risk for unintended pregnancy. Specific
early interventions are needed to reduce substance use among women of childbearing age. If
confirmed in additional large prospective studies, these findings may have important
implications for public health and clinical education, practices, and policies designed to reduce
the risk of unplanned pregnancy and improve reproductive health in this population.
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Introduction
Unintended pregnancy is a significant global public health concern affecting the wellbeing of women and their families. 169 An unintended pregnancy can be mistimed or unwanted,
indicating poor sexual health and unmet reproductive and family planning needs. 170 Unplanned
pregnancy is a known risk factor for inadequate prenatal care, pregnancy complications, poor
birth outcomes, including low birth weight and preterm birth, post-partum depression, and poor
child health and development. 171-172-173 Women experiencing unintended pregnancies report
adverse effects on their physical 174and mental health, 175-176as well as on social, economic, and
cultural aspects of their lives. 177 Unplanned pregnancy has also been associated with adverse
lifestyle behaviors during pregnancy, including inadequate vitamin intake, physical activity,
weight gain, and the use of tobacco, alcohol, and other substances harmful to the developing
fetus. 178-179
In the United States, a significant proportion of women of childbearing age use
substances. 180 The detrimental effects of substance use on women’s health and pregnancy
outcomes are well-known. 181 Women using substances in the preconception period are more
likely to continue use during pregnancy, increasing the risk for poor pregnancy and perinatal
outcomes, 182 including low birth weight (LBW), preterm birth, stillbirth, and Neonatal
Abstinence Syndrome (NAS). 183,184 Substance use during pregnancy is also linked to pregnancy
intention in a few studies. 185,186 Women with unintended pregnancies are more likely to continue
substance use during pregnancy. 187Higher rates of unintended pregnancy among substance-using
women than non-substance users were also reported in another study. 188 A study among
substance-using women revealed that 84% of pregnancies were unintended. 189 Although
substance use during pregnancy and its impact on fetal health is well established in the
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literature 190, less is known about illicit and recreational drugs during the preconception period
and their relationship with pregnancy intention.
Moreover, there is conflicting evidence on recreational drug use's effects on fertility. 191
Quitting substance use to increase fertility is also common among men and women. 192 Chronic
use of few drugs deteriorates sexual response among both males and females. 193 On the contrary,
the use of illicit and recreational sexual aid is also reported. 194 In addition, it is also linked with
risky sexual behaviors, including unprotected sex that elevates the risk of unintended
pregnancies and sexually transmitted infections (STIs). 195 Another study reported intoxication
during sexual activity and not using contraception as risk factors for unintended pregnancy. 196 In
other studies, using illicit and recreational drugs during the preconception period increased the
risk of unintended pregnancy. 197,198,199 A recently published systematic review on preventing
unintended pregnancies among women using psychoactive substances concluded that substanceusing women vary widely in demographic, reproductive, and behavioral characteristics. 200
Although several studies suggest that preconception use of illicit and recreational drugs
may be associated with an increased likelihood of unintended pregnancy differences in study
populations, sample sizes and study designs have limited conclusions regarding the significance
and magnitude of these associations. A rigorous systematic review (SR) and meta-analysis (MA)
of existing studies on this topic will help clarify the strength and magnitude of this relationship,
aid in identifying limitations in the current literature on this topic and help inform future
directions for research. However, to our knowledge, systematic reviews regarding the potential
association of preconception use of illicit and recreational drugs to risk for unintended pregnancy
in women of child-bearing age are lacking. To date, the author is not aware of any systematic
review (SR) or meta-analysis (MA) that estimated the risk of unintended pregnancy with illicit
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and recreational drug use among women of childbearing age. Understanding the link between
these factors is particularly important in light of the high prevalence of substance use and
unintended pregnancy among women of childbearing age. This study aimed to conduct a
systematic review with meta-analysis to establish evidence essential for policy and practice
efforts to improve maternal and child health. This chapter details specific aim 3 and statistical
methods used to achieve this aim.

Specific Aim 3: To conduct a systematic review with meta-analysis to assess the relation of illicit
and recreational drugs use and the likelihood of unintended pregnancy among women of
childbearing age.

Research design and Methods
Purpose
The purpose of this study was to conduct a comprehensive SR with MA to examine the
risk of unintended pregnancy among women using illicit and recreational drugs during the
preconception period. The drugs include marijuana/cannabis, cocaine, ecstasy (3,4methylenedioxymethamphetamine) or MDMA, hallucinogens, stimulants, and other street drugs.
We conducted this SR with MA by following Cochrane Collaboration's recommendations and
guidelines for conducting SR and MA for observational studies as well as the Preferred
Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) statement. This study was
registered in PROSPERO, a prospective international registry for SRs (PROSPERO 2021; ID:
CRD42021286231).
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Study eligibility
A priori eligibility criteria were set for inclusion and exclusion of the studies. We utilized
Population, Intervention, Comparison, Outcome (PICO) criteria, a Cochrane search, and an
evaluation tool 201 to ensure all key study components were included in our study screening and
assessment. Our review was limited to original studies published in English between January
2000 and June 2021 and conducted in Western developed countries (United States (US), Canada,
Western European countries, Australia, New Zealand). Additional inclusion criteria were: 1)
observational design (cross-sectional, case-control, or cohort); 2) study population/sample
comprising women of childbearing age, including pregnant women and women who had a live
birth; 3) explanatory variables included the use of any illicit and recreational drugs (e,g,
marijuana/cannabis, cocaine, ecstasy (3,4-methylenedioxymethamphetamine or MDMA),
hallucinogens, stimulants, and other street drugs) during the preconception period; 4) pregnancy
intention assessed as either the primary outcome or a variable of interest, and 5) risk estimates
presented (or calculable from available data) for the association of illicit and recreational drug
use to unintended pregnancy.
We excluded from our SR the following: review articles, comments, and letters, studies
where the outcome of unintended pregnancy was abortion, studies published in a non-English
language, studies published only in abstract or dissertation form, unpublished studies, Studies
conducted outside the general population including but not limited to sex workers, homeless
women, incarcerated, or women in substance use treatments, and studies lacking quantitative
outcome data.
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The authors utilized several resources to identify the eligible studies. These methods
include electronic databases and citation tracking from retrieved articles. Although we used
numerous sources to identify the published literature, we did not include grey literature. It
includes unpublished reports rejected or unsubmitted manuscripts. 202 Some researchers have
shown concerns regarding the methodological quality of grey literature compared to the
published studies due to the lack of peer reviews and formal quality control. 203,204 Thus, the
inclusion of grey literature may jeopardize the quality of MA, given that it depends on the
quality of included studies in the analysis. However, there is limited evidence regarding the
lower quality of grey literature than the published literature. 205 It is also thought that excluding
grey literature may overestimate the effect size (ES) since studies with non-significant findings
are less likely to be published. 206 In the current SR with MA, we excluded grey literature due to
limited resources and difficulty accessing the unpublished literature.
Data sources
The literature search plan utilized numerous resources, including electronic searches in
multiple databases, citation indices of pertinent review articles and papers identified as
potentially eligible, and contact with experts in the field. To develop a specific search strategy
for each database, an information retrieval specialist (Director Health Sciences Library, SA)
guided the planning process to create correct search strings for each electronic database search.
To begin the electronic databases search strings, MeSH (medical subject heading) and the
Boolean operator were created. For the current study, we searched the following databases from
October 18-26, 2021: (1) PubMed (MEDLINE), (2) Scopus, (3) CINAHL, (4) PsychINFO, and
(5) Web of Science. All aspects of literature were documented, including data source, journal,
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date, etc. We initiated the search by conducting a preliminary search in PubMed using MeSH
terms. The Pubmed search strings, including MeSH term, were as follows:
("pregnancy, unplanned"[MeSH Terms] OR "pregnancy, unwanted"[MeSH Terms]) OR
(unintended pregnancies OR unintended pregnancy) OR (unplanned pregnancies OR unplanned
pregnancy) OR (unwanted pregnancies OR unwanted pregnancy) AND "drug abuse") OR "drug
dependence") OR "drug addiction")) OR]) ("substance-related" AND "disorders") OR
"substance-related disorders" OR ("drug" AND "habituation") OR "drug habituation").
Each search was conducted separately and was downloaded and saved as a separate file
using Endnote(X9). The search on the electronic database was supplemented by a hand search
for citation tracking from the reference list of the included articles and relevant review articles.
The duplicates were removed both electronically and manually.
Study Selection
Two researchers (SS and RM) independently screened studies based on pre-defined
eligibility criteria for inclusion. We reviewed the titles and abstracts of individual studies. Fulltext articles were retrieved and reviewed if they appeared to meet the inclusion criteria. After
completing the individual study selection, the two reviewers screened every selection for
agreement. A third reviewer (AU) resolved the matter in cases of disagreement. Using Cohen's
kappa statistics, 207 the overall agreement rate between the two researchers before correcting
discrepancies was 0.86.
Data Abstraction
A detailed codebook was created in Microsoft Excel (version 2112). This codebook
included studies' characteristics, i.e., authors' name, year of publication, region of study, data
source, study design, sample size, outcome and exposure variables, population characteristics,
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and statistical findings required to calculate the effect size. The codebook was pilot-tested and
revised. The two authors (SS and RM) coded and extracted the information from each study
independently to avoid any abstraction bias. The two researchers then compared the data for
accuracy and consistency to reach 100% agreement. A third reviewer (AU) resolved the matter
in case of disagreement.
Risk of Bias Assessment
After the full-text review of the studies included in the SR and MA, the risk of bias
assessment was performed to capture and analyze variation among the studies. The risk of bias
describes "a systematic error or deviation from the truth, in the results or inferences." The biases
reported in observational studies include (1) selection bias (sampling frame, recruitment,
retention, nonresponse, loss to follow-up), (2) social desirability bias, (3) recall bias, (4)
confounding and residual confounding bias, (5) measurement bias, and (6) interviewer bias.
Several tools have been used to evaluate the risk of bias and quality of studies with no gold
standard established. 208 However, one tool, the Newcastle-Ottawa scale (NOS), is commonly
used. 209
The NOS results from an ongoing collaborative effort between the Universities of
Newcastle, Australia, and Ottawa, Canada. Separate scales are available for cohort, crosssectional and case-control studies. Each scale consists of eight items, with three dimensions
including selection, comparability, and outcome or exposure. A star system is used ranging from
0-9; the higher number of stars depicts the higher quality of studies. The content validity of the
NOS is based on a critical review of the items by several experts who evaluated its clarity and
completeness to assess the quality of studies included in SR and MA. 210
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Statistical Analysis
After data cleaning in Microsoft Excel (version 2112), qualitative and descriptive
analyses with frequencies and percentages were generated.
Qualitative Analysis
A detailed description of the included studies was created for quality analysis, including
studies and populations characteristics.
Calculations for Effect Size
The effect size depicts the strength and the direction of association between two
variables. In the current study, we used the OR with 95%CI as our effect size measure to
estimate the risk of unintended pregnancy among women using drugs.
Pooling of Effect Size's
The inverse variance (IVhet) model analyzed and summarized the results using MetaXL
(version 5.3). 211 The IVhet model provides a quasi-likelihood-based expansion of the CI around
the inverse variance weighted pooled estimate when studies exhibit heterogeneity (without
inappropriate changes to individual study weights, as observed in the random-effects model),
keeping the mean squared error (MSE) lower than with the random effects estimator. 212 This
method is regarded as the measure of precision and is inversely related to the size of confidence
intervals (CIs). The study with more precision, i.e., smaller CIs, will contribute more to the
overall ES than those with wider CIs. The IVhet method also takes sample size and withinsample heterogeneity into account. Larger sample sizes and those with less heterogeneity
produce more precise estimates.212 Heterogeneity of the effect estimates of different studies was
assessed using two statistics, Cochran's Q test statistic and its corresponding p-value, and I2
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statistics. The major purpose of conducting an MA is to investigate the potential sources of
heterogeneity of results in the included studies. 213 I2 statistics narrate the variations across the
studies due to heterogeneity rather than chance.213 It also summarizes the input and extent of
heterogeneity to determine the robustness of overall conclusions. 214 I2 is an intuitive expression
of the inconsistency of studies results and is calculated as 100% x (Q -df)/Q, where Q is
Cochran's heterogeneity statistics, and df is the degree of freedom. For current study, I2 was
classified (0% - 25%) as trivial, (25.1% - 50%) as low, (50.1% - 75%) as moderate, and (75.1% 100%) as high. The findings were interpreted regarding the magnitude and direction across
studies, evidence for heterogeneity, and the clinical implications of the degree of
inconsistency. 215
We created Forest plots to exhibit the distribution of effect estimates across studies.
Publication bias, i.e., the tendency of authors to submit and journals to publish the articles with
statistically significant findings. A DOI plot with an LFK index was used in the current study to
assess any small study effect and publication bias. An asymmetrical DOI plot and LFK index
value outside the +1 and -1 is considered a publication bias. 216 We also performed influence
analysis to assure the robustness of the overall findings. 217 An influence analysis is meant to
determine each study's influence on overall results and determine if the study with a larger
influence can distort the overall ES. 218 A cumulative analysis was performed to detect the
temporal trends in effect size. 219
Results
Search results
The flow chart diagram showing the comprehensive search for studies is presented in
Figure 1. Of the 4920 records identified from five electronic databases, 152 were selected based
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on title screening. After abstract screening and removing duplicates both electronically and
manually, 22 potentially eligible articles were identified for detailed review. Of these, 14 were
excluded. The excluded articles with reasons are listed in a supplemental file (Supplemental File
1). Eight studies meeting inclusion were included in the current SR with MA.
220,221,222,223,224,225,226,227

Description of included studies
The included studies were published between 2004 and 2020, while the data collection
period ranged from 1997 to 2016. Five studies were conducted in the US, 220-223,226two studies in
the United Kingdom (England, Scotland, and Wales),225,227, and one study in Canada224. The
studies included six cross-sectional investigations,220,223,227 one case-control study,221 and one
prospective cohort study.222 (Table2) The study populations ranged from pregnant
women,220222,222,223 women delivering a live birth,221,226 to women of childbearing age.224,225,227
Only two studies utilized hospital data.222,223 The remainder were based on large nationally
representative data sources, including the National Births Defects Prevention Study,221
Pregnancy Risk Assessment Monitoring System (PRAMS),226 Office of Family Health, New
York City Department of Health and Mental Hygiene,220 Maternity Experience Survey,224 and
National Survey of Sexual Attitudes and Lifestyles (Natsal-3).225,227
Table 3 provides a detailed description of the exposure and outcome variables. In
addition to illicit and recreational drugs, smoking and alcohol consumption were also reported in
seven of the eight studies.220-221,224-225 Substance use was assessed by employing self-reported
questionnaires in all studies. The prevalence of illicit and recreational drugs varied from 4%21%.220,223 A detailed description of population characteristics, including age, race and ethnicity,
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marital/relationship status, education, insurance, rurality, and parity, is available in the additional
file. (Supplemental file 3)
Prevalence and correlates of unintended pregnancy
Pregnancy intention was measured by validated tools, including London Measure of
Unplanned Pregnancy (LMUP)223,225,227 PRAMS226226, or questions explicitly investigating the
intention to become pregnant about their recent pregnancy.220,221222 The prevalence of unintended
pregnancies varied from 5.3%225 to 82%.220220 (Table 3). The average crude prevalence in the
seven studies using nationally representative samples was 44%. The most commonly reported
determinants of unintended pregnancy included age <20 years, 220-221,224,227 non-Hispanic
White220 and Black race,221 not married or not having a partner, 220,224 having one or more
previous pregnancies,224 previous adverse pregnancy outcomes, 221 lower educational attainment,
224,227

and abusive relationship.224 Use of substances in addition to illicit and recreational drugs

included smoking 221-224,227and alcohol consumption. 220223,225-227
Risk of Bias Assessment
Risk of bias assessment was performed using NOS scales for cross-sectional, cohort, and
case-control studies. Overall study level risks of bias are shown in Table 1, and results for each
item from individual studies are shown in the additional file (Additional file 2). The studies
ranged from 5- 8 out of 9 stars on the NOS scale, indicating a low to moderate risk of bias. Most
study populations were representative of the target population, with large sample sizes
(n’s=2654223 to 8886220) in all but one study223. For substance use, self-reported data were used,
prone to recall and other information bias. Similarly, studies used a retrospective self-reported
validated questionnaire for outcome assessment, increasing the risk of recall bias.
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Primary Outcome
The results of all studies, including crude and adjusted ORs and information on factors
adjusted for, are detailed in Table 4. Overall, there was a statistically significant and positive
association between preconception illicit or recreational drugs use and unintended pregnancy
(Pooled OR=1.84, 95%CI=1.4 – 2.4). The inverse variance model MA results for the association
between illicit and recreational drugs and unintended pregnancy are presented below. The forest
plot exhibiting the effect estimates with 95%CI is shown in Figure 2. The Oulman et al., 2015
study had the smallest CIs and accounted for 28.5% of the overall estimates in the current MA.
224

In contrast, the small cohort study by Lundsberg et al., 2020 accounts for only 0.7% of the

overall estimates and reported (0.27 – 7.41) the widest confidence intervals (Figure 2. Forest
plot).223 The overall pooled OR showed that the women using illicit and recreational drugs
during the preconception period have a statistically significant increased likelihood of
unintended pregnancy compared to women who did not use drugs (POR=1.84, 95%CI=1.4 –
2.4). A moderate heterogeneity (I2 =66%) across studies, with significant Cochrane Q statistics
(Q= 20.41, p-value = 0.00) was also noted. However, after deleting each study, the influence
analysis results yielded pooled ORs ranging from 1.65 – 2.1 (Table 6). All ORs remained
significant; the very modest variation in ES across studies suggests a lack of outliers or highly
influential studies among the investigations included in the MA. The cumulative analysis
comparing ORs by year of publication did not show significant changes in the magnitude of risk
over the two decades. (2000-2020, Table 7). DOI plot (Figure 3. DOI plot) was asymmetrical,
and the LFK index was 2.66 indicating a positive asymmetry. As illicit and recreational drug use
is often considered a risk factor for unintended pregnancy, and studies yielding non-significant
findings may be less likely to be published, investigations confirming an association are more
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likely to be published. However, the interpretation regarding a bias requires caution due to the
small number of studies (n=8), which increases the likelihood of an asymmetry.

Discussion
Principal finding
This comprehensive SR with MA assessed the relationship between illicit and
recreational drugs during the preconception period and the likelihood of unintended pregnancy
among women of childbearing age. Pooled findings of the eight eligible studies indicated a
significant, 1.84-fold increased risk of unintended pregnancy in women reporting preconception
use of illicit and recreational drugs, suggesting that these substances may increase the risk of
unplanned pregnancy in women of childbearing age. The results of influence analysis support the
robustness of these findings. However, moderate heterogeneity was noted across studies, likely
reflecting differences in study population characteristics, measures of drug use, factors adjusted
for, and other methodological components, potentially limiting definitive conclusions. The
cumulative analysis indicated a consistent magnitude of risk over the two decades, adding to the
robustness of the current findings.
The pooled findings of this SR also indicate a high prevalence of both illicit and
recreational drug use and unintended pregnancy among women of reproductive age. Broadly
consistent with our results, prior studies have suggested about half of the pregnancies in the
US 228 and one-third of those in the UK and other European countries are unintended.227
Unintended pregnancy is considered a global standard or benchmark of reproductive health and
has severe consequences for women's and children's health and wellbeing. 229- 230 High prevalence
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of unintended pregnancy indicates unmet reproductive and family planning needs among women
of childbearing age.
Substance use poses serious health risks to women of childbearing age. As noted above,
the reported prevalence of illicit and recreational drug use during the preconception period was
high, varying from 4%220 – 21% 223 in the studies included in this SR. Other studies investigating
the prevalence of illicit drug use among women of childbearing age also reported similar
findings. 231,232 Preconception substance has been shown to increase the risk for substance use
during pregnancy. 182 These exposures have severe effects on fetal growth, development, and
birth outcomes. 233 Moreover, although most women stop using illicit and other substances upon
pregnancy recognition, fetal exposure to these potential teratogens can still occur during the
initial 4 – 6 weeks or later if the determination of pregnancy is delayed, 234 specifically among
women using substances in the preconception period.
Moreover, prior studies have suggested that women with unintended or unwanted
pregnancies are more likely to continue substance use during pregnancy than are those with
planned pregnancies. 235 To address these outcomes, the advocates for women and child health
suggest implementing programs to improve preconception health for all women of childbearing
age. 236 Researchers at the Center for Disease Control and Prevention (CDC) have identified
several evidence-based interventions promoting preconception care and pregnancy-related
outcomes, including risk screening and health promotion. 237 An essential aspect of preconception
care is pregnancy planning. Data from a telephonic survey conducted in Minnesota and
Washington revealed that pregnancy planning was associated with health behaviors that
influence birth outcomes, including vitamin intake and substance use. 238 This emphasizes
focusing the screening and education efforts to address substance use among women of
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childbearing age, promoting public awareness of the effects of substance-exposed pregnancy,
and encouraging access to effective contraception should be prioritized. 239 Brief public health,
clinical, and integrated behavioral interventions aimed at screening and educating women in the
Obstetrician-Gynecologists, and family planning clinics have impacted improving health
outcomes. 240,241
The rates of unintended pregnancy vary among the fractions of the population depending
upon the individual, environmental, social factors, and health and family planning servicesrelated elements. We also assessed the correlates of unintended pregnancy reported in the
included studies to explore this. Studies reported younger maternal age (<20 years) as a
significant predictor of unintended pregnancy. 221,222,225,227 This is consistent with the previously
published research where most teen pregnancies have been regarded as unplanned or
unwanted. 242 Other factors associated with unintended pregnancy in the studies included in this
review were low educational achievement, 243 non-Hispanic Black race, 244 lack of a partner, 245
history of prior pregnancy 246 or adverse pregnancy outcome, 247 and initiating sexual activities
before the age of 16 years 248 also reported in other investigations. Poor socioeconomic status is
also an established independent risk factor for unintended pregnancy. 249 Notably, in the present
SR, the study conducted among urban women with low-socioeconomic status reported over 80%
of pregnancies to be unintended.23 Moreover, as reported in the literature, 250 women
experiencing physical or emotional abuse were more likely to experience unplanned pregnancy
outcomes. 251 In addition, three studies documented significant associations between smoking
and alcohol consumption and unintended pregnancy in the adjusted analyses.188,221-222 Previously
published literature has shown the use of drugs as a cause of risky sexual behaviors, including
unprotected sex. 252
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Implications
Implications for research
The results of our SR with MA have several implications for future research. First, most of the
studies included were cross-sectional in design, precluding determination of causality. Second,
seven out of eight studies used retrospective measurement of pregnancy intention. 220-221,223-227
Pregnancy intention was measured post-partum or even months after the birth, raising the
likelihood of recall bias. The pregnancy outcome may affect the accuracy of parental recall and
are likely to bias studies toward the null. 253 It is more evident since parents originally not
intending the pregnancy are more likely to recall it as intended than the parents planning to
become pregnant and recall it as unintended, leading to underestimating the full impact of
unintended pregnancy. 254,255 Third, illicit and recreational drugs may be subjected to underreporting due to social desirability bias and the stigma of substance use. All the included studies
in the current SR with MA used self-reported data, which may lead to underestimating the
prevalence of drug use. 256 It is challenging to gauge substance use prevalence due to underreporting, inconsistent screening and drug testing among providers, and inaccurate reporting
systems, so findings must be interpreted cautiously. Finally, based on the risk of bias assessment,
future studies need to improve their reporting regarding 1- evaluation of potential sources of
bias, 2- methods used to handle missing data, 3- reporting response rate, 4- providing a
comparison of responders and non-responders to evaluate the risk of selection bias, 5- factors
adjusted for in the multivariable analysis.
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Implications for practice
The pooled findings of the current SR with MA suggest that illicit and recreational drugs
during the preconception period may significantly increase the risk of unintended pregnancy.
These findings have important implications for practice if confirmed in future extensive,
prospective studies. Given the adverse effects of drugs on maternal and child healthError! Bookmark
, preventing unintended pregnancies among this high-risk group should be recognized as

not defined.

a public health priority. Furthermore, the findings of this study support screening all women of
childbearing age for substance use as recommended by the CDC 257 and the American College of
Obstetricians and Gynecologists (ACOG) 258. However, evidence-based and culturally tailored
screening interventions are needed due to the personal and institutional stigma of substance
use. 259

Strength and limitations
To the best of the authors' knowledge, this is the first SR with MA to investigate the
association of illicit and recreational drug use to the likelihood of unintended pregnancy among
women of childbearing age. This study used the inverse variance model (IVhet) that takes
studies’ precision, sample size, and within-study heterogeneity into account, producing more
precise estimates. Thus, the current results provide more accurate information than the random
effect model.212. We used the DOI plot and LFK index to assess publication bias. These tests are
more precise while examining the small study effects than the traditional tools. 260 The influence
analysis results indicated modest variation in the effect size depicting a lack of outlier or highly
influential study. The findings of cumulative analysis also suggested the consistency of
magnitude of risk over two decades, adding to the robustness of current findings.
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The present study results should be interpreted with caution due to the following
limitations. First, SR with MA is inherently vulnerable to biases in the original studies and
cannot make up for the poor quality of original studies. 261 Second, MA relies heavily on
published studies. It is more difficult to publish studies with no statistically significant results,
potentially leading to disproportionate reporting of significant findings (publication bias). In our
assessment of potential publication bias, evaluation using DOI plots and the LFK index indicated
a moderate risk of publication bias. Third, literature search bias (i.e., failure to identify all
relevant studies) is a potential problem in all SRs. However, we performed an extensive search
following the pre-defined criteria. Thus, we expect this bias to be minimal. Fourth, while interrater agreement can be a potential problem during the study selection, data abstraction, and risk
of the bias assessment process, the authors reached a consensus in each of these domains in
conducting this SR with MA. Fifth, the current study was limited to studies published in the
English language, introducing another potential bias. However, any resulting bias is unlikely to
have appreciably affected our findings, as published literature has shown meta-analyses
restricting studies by language overestimate the magnitude of the association by only 2%. 262
Sixth, 75% of the included studies were cross-sectional in design, limiting the assessment of
cause-effect relationships. Moreover, most(all) studies relied on self-report, potentially
introducing recall and other information bias. Finally, we could not perform a meta-regression
for the determinants of unintended pregnancy among women using substances due to the
differences in the classifications of variables and lack of data for a few potential predictor
variables.
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Conclusion
In this SR and MA of eight observational studies, preconception use of illicit and
recreational drugs among women of childbearing age was positively and significantly associated
with unintended pregnancy. The findings of this SR with MA may have important implications
for future research, policy, and practice. Additional rigorous prospective research is needed to
address current studies' design and methodological limitations and improve reporting bias. This
SR with MA further highlights the need for universal screening among all women of
childbearing age, especially in light of the known adverse effects of both illicit and recreational
drug use on maternal and child health. Our findings also support evidence-based and culturally
sensitive screening and family planning interventions to prevent unintended pregnancy and
improve health outcomes.
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Chapter 5
Discussion
Summary of Key Findings
Overview
The current studies were aimed to determine the extent and nature of unintended
pregnancy risks associated with substance use during the preconception period among women of
childbearing age in the US. We looked at the sociodemographic determinants of unintended
pregnancy among various substance-using women and continued that exploration among women
using polysubstance. Finally, our third study established a systematic review with a metaanalysis of the risk of unintended pregnancy among women using illicit and recreational drugs.
Although substance use during pregnancy and its adverse outcomes on the child's health have
been focused on over the years. Fewer studies have explored women’s pregnancy intentions in
the circumstances involving various forms of substance use in the preconception period. Also,
only a few studies that have investigated the risk of unintended pregnancy with substance use are
limited to small-scaled hospital-based studies. The authors are unaware of any study
investigating the risk of unintended pregnancy with polysubstance use and its predictors among
women of childbearing age.
We performed a secondary cross-sectional data analysis on sizeable national
representative data from PRAMS (phase 8) in the first two aims. PRAMS is a national maternal
and child health data providing information on a range of estimates during preconception,
pregnancy, and postpartum periods. By using PRAMS data, we met the goal of utilizing a large
representative sample. The sample consisted of 74,543 women giving live births during 2016-17.
For our third study, we conducted an SR with MA to analyze the risk of unintended pregnancy
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associated with the use of illicit and recreational drugs. A total of 4,920 records were screened
from various resources based on the predetermined eligibility criteria as follows; (1)
observational studies, (2) studies with pregnancy intention as the primary outcome or variable of
interest, (3) studies with pregnant women, or women giving live births, (4) exposure variable
include illicit and recreational drugs specified by authors, (5) studies conducted in the US, UK,
Australia, New Zealand, (6) studies published in the English language, (7) studies published
from January 2000 – June 2021, and (8) studies conducted in the general population. The
literature search plan utilized numerous resources, including (1) electronic searches in multiple
databases PubMed (MEDLINE), Scopus, CINAHL, PsychINFO, and Web of Science in October
2021, (2) citation indices of pertinent review articles and papers identified as potentially eligible
(citation tracking). The summaries of the key findings from all three aims are discussed below.
Preconception Substance Use and the Risk of Unintended Pregnancy
Our first study aimed to examine the association of preconception substance use and
unintended pregnancy among women of childbearing age in the US. As an association existed,
we compared substance use between subtypes of unintended pregnancies, i.e., mistimed,
unwanted, and ambivalent. The study also aimed to assess the association
between sociodemographic factors and unintended pregnancies among women who use
substances. We used data from PRAMS 2016-17 surveys to achieve this aim. The sample
comprised 74543 women giving live births during 2016-17 and participated in the PRAMS. In
the current sample, about 41% of the pregnancies were unintended. Of those reports, 19.5% were
mistimed, 6.2% were unwanted, and 15.3% were described as ambivalent these reports similar to
the national prevalence. 263 A higher prevalence of substance use in the preconception was noted.
About a half of the women documented alcohol use, while one-third revealed binge drinking.
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Cigarette smoking was reported by 17%, tobacco/nicotine products 10.6%, Cannabis 10%,
prescription opioids 5.2%, and illicit and recreational drugs 4.2%. The adjusted odds ratios
indicated increased likelihood of unintended pregnancy with alcohol consumption (AOR: 1.05,
95%CI: 1.0-1.1), smoking (AOR: 1.5, 95% CI: 1.4-1.6), nicotine/tobacco (AOR: 1.4, 95% CI:
1.3-1.5), cannabis (AOR: 1.9, 95% CI: 1.5-2.3), illicit/recreational drugs (AOR: 1.7, 95% CI:
1.2-2.4). A higher magnitude of risk was noted with heavy smoking (AOR: 1.9, 95%CI: 1.5-2.3),
heavy (AOR: 1.9, CI: 1.5-2.2), and binge drinking (AOR:1.2, 95%CI:1.04-1.4). A similar pattern
was observed with subtypes of unintended pregnancy, with a higher risk noted for unwanted
pregnancies. Many of the associations found in the current study are previously reported in the
literature, such as smoking, illicit drugs, tobacco, and cannabis. 264-265-266 The likelihood of
unintended pregnancy was significantly elevated with heavy smoking, high alcohol consumption,
and binge drinking, similar to what is reported in the literature. 267-268
The results of the stratified analysis to compare the maternal characteristics showed that
women using different substances also vary in their characteristics. A more significant fraction of
pregnancies were unintended among the illicit/recreational drugs using women; these women
also reported annual income below FPL and inadequate PNC. A higher fraction of opioid-using
women reported having depression and anxiety and experiencing physical and emotional abuse
than other women. After controlling for other risk factors, the regression analysis results
indicated that urban living women who were using prescription opioids were at three times
higher risk of unintended pregnancy than women in rural areas, while among illicit and
recreational drug users two folds risk was observed. These results align with another study where
eight out of ten pregnancies were unintended, and the use of illicit drugs was significantly
associated with unintended pregnancy. 269Having an annual income less than FPL was a strong
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predictor of unintended pregnancy among all substance users, specifically among prescription
opioid users. These findings are consistent with the existing literature showing that less annual
income than FPL was independently associated with pregnancy intention. 270 It is also reported
that women below FPL were five times more likely to experience unintended pregnancies. 271
Among all substance users, age < 17 was a significant predictor of unintended pregnancy
compared to the women aged 35 years and above. These findings are consistent with the existing
literature where the proportion of unintended pregnancy decreases with age. The adolescents
aged 15-19 had the highest rates of unintended pregnancy than any other age group. 272-273 Our
findings that not having a graduate education and marital status other than married increased the
risk of unintended pregnancy are consistent with the previous studies. Women from racial and
ethnic minorities are at increased risk of experiencing an unintended pregnancy. 274 Our study
found an increased risk among Black women using alcohol and tobacco/nicotine, opioid using
non-Hispanic Whites, and illicit/recreational drugs using women from other races. Various social
and economic factors contribute to health disparities. A study based on National Survey of
Family Growth data reported age, relationship status, annual income, education, and insurance
contributing factors to the higher likelihood of unintended pregnancy. 275 The findings of our
study provide insight into the factors contributing to poor reproductive health among women
with substance use. It is crucial to identify the women at higher risk and ensure that younger
women, minorities, and women with poor socioeconomic status have information and access to
reproductive and family planning services. 276
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Polysubstance Use and the Risk of Unintended Pregnancy
This study aimed to examine the association between polysubstance use and unintended
pregnancy among women of childbearing age and to assess the predictors of unintended
pregnancy among women co-using substances. The study sample comprised 74543 women
delivering live births during 2016-17 and participated in the PRAMS survey. In this sample,
about 56.5% of the respondents reported drinking alcohol; of those 33% revealed heavy or binge
drinking. About 17% of the sample smoked cigarettes, among those 27.1% were heavy smokers.
A higher prevalence of polysubstance use during the preconception period was observed in the
current study. Among alcohol drinking women, one quarter (25.3%) were heavy smokers, 13%
used cannabis, and 5% used opioids. Among smokers, 25.8% were co-using cannabis, 12.5 %
used illicit drugs, 33% used other tobacco/nicotine products, and about 10% used opioids. A
higher proportion of women reporting heavy smoking and heavy or binge drinking were co-using
other substances. The regression analysis results revealed that alcohol drinking women and cousing other substances were at higher risk of untended pregnancy. Statistically significant and
positive association of unintended pregnancy was observed with heavy smoking (AOR: 1.5,
95%CI:1.4 – 1.6), cannabis (AOR: 2.0, 95%CI:1.6 – 2.4), tobacco/nicotine (AOR: 1.6,
95%CI:1.4 – 1.7), and illicit/recreational drugs (AOR: 1.8, 95%CI: 1.1 – 2.7). Higher odds of
unintended pregnancy were noted among heavy or binge drinkers with smoking (AOR: 1.9,
95%CI: 1.5 – 2.4), cannabis use (AOR: 2.1, 95%CI: 1.4 – 3.1), tobacco/nicotine (AOR: 2.3,
95%CI: 1.7 – 3.1). The risk of unintended pregnancy was not statistically significant with co-use
of opioids with alcohol (AOR: 1.3, 95%CI: 0.9 – 1.9) and heavy or binge drinking (AOR: 1.4:
95%CI: 0.6 – 3.6) after adjusting for potential confounders. To identify the predictors of
unintended pregnancy among women co-using alcohol with other substances. Four highly
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prevalent patterns of polysubstance use were identified, including alcohol and smoking
(N=9,145), alcohol and cannabis (N=1511), alcohol and illicit/recreational drugs (N=346), and
smoking and cannabis (N=1091).
The logistic regression analysis revealed urban living, income below FPL, and marital
status other than married were significant predictors of unintended pregnancy among
polysubstance users. Women older than 35 years (AOR: 2.0, 95%CI: 1.3 – 3.0) and Black race
(AOR: 1.4,95%CI: 1.1 – 1.7) increased the odds of unintended pregnancy among women cousing alcohol and smoking. Education less than or equal to high school was significantly
associated with unintended pregnancy among alcohol and smoking (AOR: 2.8, 95%CI: 2.3 – 3.6)
and alcohol and cannabis users (AOR: 2.6, 95%CI: 1.6 – 4.6). Marital status other than married
had higher odds of unintended pregnancy among alcohol only (AOR: 3.2, AOR: 3.0 -3.5),
alcohol and smoking (AOR: 2.4, 95%CI: 2.0 -2.8), and alcohol and cannabis users (AOR: 2.8,
95%CI: 1.8 – 4.4).
Our findings from the current population-based sample of US women demonstrated a
positive and statistically significant association between polysubstance use during the
preconception period and the risk of unintended pregnancy. The prevalence of unintended
pregnancy was 39% for alcohol consumers and the highest for heavy smokers (62.5%).
However, co-using alcohol with smoking, illicit substances, or cannabis led to a higher
prevalence of unintended pregnancy (60%). Cannabis was the most commonly co-used substance
among smokers and alcohol drinkers. Compared to moderate drinking and smoking, women with
heavy/binge drinking and heavy smoking had a high prevalence of polysubstance use. These
findings suggest a potential sequel that starts with the initiation of substance use with the legal
substances, particularly tobacco and alcohol, and progressing towards heavy smoking/drinking
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and proceeding to co-using other substances. This pattern is in alignment with the gateway drug
hypothesis. This hypothesis suggests the beginning of substance use with alcohol, tobacco, and
cannabis that escalates to using more addictive substances, including illicit drugs. 277,278
Our study noted the most frequent polysubstance use patterns, including alcohol,
cannabis, and tobacco, which is similar to the findings of another study. 279 The results showed
that most women reporting polysubstance use resided in urban areas, were 20-34 years of age,
were non-Hispanic White, had education ≤ high school, were not married, and their annual
income was below the FPL. Polysubstance use among women of childbearing age is common
and leads to maternal and child health risks. Our study’s findings suggest the need for
interventions addressing polysubstance use in women of childbearing age. The United States
Preventive Services Task Force (USPSTF) 280, CDC 281, and American College of Obstetricians
and Gynecologists (ACOG) 282 recommend universal screening of women of childbearing age
and pregnant women. There is evidence suggesting the benefits of screening and brief
interventions leading to a reduction in alcohol use, smoking, and illicit drug use 283,284,285.

Unintended Pregnancy Among Women of Substance Use: A Systematic Review with MetaAnalysis
The purpose of our third study was to conduct a systematic review with meta-analysis to
assess the relation of illicit and recreational drugs use and the likelihood of unintended
pregnancy among women of childbearing age.
We included eight studies that met our review's inclusion criteria (N=38,520 women).
The findings suggest a statistically significant and positive association between preconception
illicit or recreational drugs use and unintended pregnancy (Pooled OR=1.84, 95%CI=1.4 – 2.4).
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A moderate heterogeneity (I2 =66%) across studies, with significant Cochrane Q statistics (Q=
20.41, p-value = 0.00) was also noted. The influence analysis results after deleting each study
one by one yielded pooled ORs ranging from 1.65 – 2.1 (Table 6). All ORs remained significant;
the very modest variation in ES across studies suggests a lack of outliers or highly influential
studies among the investigations included in the MA. The cumulative analysis comparing ORs
by year of publication did not show significant changes in the magnitude of risk over the two
decades. The DOI plot was asymmetrical, and the LFK index was 2.66 indicating a positive
asymmetry that might happen due to a small study effect or fewer studies in the review.
The prevalence of reported illicit and recreational drug use in our studies ranged from
4.0-21.0%, which is in the range of the prevalence reported in the other studies. 286,287The
prevalence of unintended pregnancies varied from 5.3%225 to 82%.220 Average crude prevalence
in the seven studies using nationally representative samples was 44%. In the systematic review,
determinants of unintended pregnancy included age <20 years,220-221,225,227 non-Hispanic White220
and Black race, 221 not married or not having a partner, 220,224 having one or more previous
pregnancies, 224 previous adverse pregnancy outcomes, 221 lower educational attainment, 224,227
and abusive relationship.224 Use of substances in addition to illicit and recreational drugs
included smoking221,224-227 and alcohol consumption.223,225,227
Preconception substance has been shown to increase the risk for substance use during
pregnancy. 182 These exposures have known adverse effects on fetal growth, development, and
birth outcomes. 288 Moreover, women with unintended or unwanted pregnancies are more likely
to continue substance use during pregnancy than are those with planned pregnancies. 289
Substance exposed pregnancies are at risk for poor pregnancy and perinatal outcomes, 290

75

Shafique Dissertation

including but not limited to low birth weight (LBW), preterm birth, stillbirth, and Neonatal
Abstinence Syndrome (NAS). 291,292
To improve birth outcomes, women and child health advocates suggest implementing
programs to improve preconception health for all women of childbearing age. 293 The Center for
Disease Control and Prevention (CDC) has identified evidence-based interventions promoting
preconception care and pregnancy-related outcomes, including risk screening and health
promotion. 294 An essential aspect of preconception care is pregnancy planning associated with
health behaviors influencing birth outcomes. 295 Promoting public awareness of the effects of
substance-exposed pregnancy might strengthen the efforts to prevent substance use among
women of childbearing age. Brief interventions to screen and educate women and provide access
to effective contraception in the Obstetrician-Gynecologists and family planning clinics have
improved health outcomes. 296,297
To the author's knowledge, this is the first SR with MA to assess the relation of illicit and
recreational drugs use and the likelihood of unintended pregnancy among women of childbearing
age. Our findings suggest that the preconception use of illicit and recreational drugs among
women of childbearing age was positively and significantly associated with unintended
pregnancy. The findings of this SR with MA may have important implications for future
research, policy, and practice. Our results indicate the need for a more rigorous methodology to
improve the study quality. The risk of bias assessment regarding the precise gauge of the
prevalence of substance use and pregnancy intention suggested thats future studies need to
improve their reporting regarding the study design and evaluation of potential sources of bias.
Given the high prevalence of both unintended pregnancy and illicit and recreational drugs in the
preconception period preventing unintended pregnancies among this high-risk group should be
recognized as a public health priority.
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Strengths of the dissertation
The primary strength of our study is using a large, population-based, representative
sample of US women of childbearing age. For the first two studies, we used national data from
PRAMS 2016-17, providing information on a range of social, demographic, mental health, and
substance use variables. The study used a granular approach and provided an in-depth analysis of
the significant determinants of unintended pregnancy among types of substance use. To the best
of our knowledge, this is the first study examining the association between
substance/polysubstance use and unintended pregnancy among US women of childbearing age.
We also performed a stratified analysis to compare the characteristics of groups with highly
prevalent patterns of substance use and co-using substances. The study also provided a
breakdown of sub-types of unintended pregnancy, i.e., mistimed, unwanted, and ambivalent
pregnancies, and their risk with a range of substance and polysubstance use.
For our third aim, to our knowledge, this is the first SR with MA to investigate the
association of illicit and recreational drug use to the likelihood of unintended pregnancy among
women of childbearing age. This study used the inverse variance model (IVhet) that takes
studies’ precision, sample size, and within-study heterogeneity into account, producing more
precise estimates. Thus the current results provide more accurate information than the random
effect model.212. Using the DOI plot and LFK index to assess publication bias is another
advantage over previous studies. These tests are more precise while examining the small study
effects than the traditional tools. 298 Another merit of our research was the influence analysis
indicating a lack of an outlier or highly influential study and modest variation in the effect size.
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The results of the cumulative analysis also suggested the consistency of magnitude of risk over
two decades, adding to the robustness of current findings.

Limitations of the dissertation
Despite the strengths, the study has a few limitations that should be considered while
interpreting the findings. For our first two aims, the analysis is limited to women delivering live
births, leading to underreporting adverse outcomes (miscarriage or stillbirth) associated with
unintended pregnancy and substance use. Secondly, this cross-sectional study cannot predict
polysubstance use patterns over time. However, estimating preconception substance use might
provide a temporal relationship to measure the risk associated with unintended pregnancy. Third,
due to retrospective measurement, recall bias may influence pregnancy intention. Fourth,
PRAMS questionnaires are self-reported and may be subjected to under-reporting of behaviors
perceived to be unhealthy. Substance use is prone to underreporting owing to social desirability
bias and the stigma of illicit drug use.
The results should be interpreted with caution for our third aim due to the following
limitations. First, SR with MA is inherently vulnerable to biases in the original studies and
cannot make up for the poor quality of original studies. 299 Second, MA relies heavily on
published studies. It is more difficult to publish studies with no statistically significant results,
potentially leading to disproportionate reporting of significant findings (publication bias). In our
assessment of potential publication bias, evaluation using DOI plots and the LFK index indicated
a moderate risk of publication bias. Third, literature search bias (i.e., failure to identify all
relevant studies) is a potential problem in all SRs. Although, we performed an extensive search
according to the eligibility criteria. Thus, we expect this bias to be minimal. Fourth, while inter-
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rater agreement can be a potential problem during the study selection, data abstraction, and risk
of the bias assessment process, the authors reached a consensus in each of these domains in
conducting this SR with MA. Fifth, the current study was limited to studies published in the
English language, introducing another potential bias. However, any resulting bias is unlikely to
have appreciably affected our findings. Previous literature has revealed that meta-analyses
restricting studies by language overestimate the magnitude of the association by only 2%. 300
Sixth, 75% of the included studies were cross-sectional in design, limiting the assessment of
cause-effect relationships. Moreover, most(all) studies relied on self-report, potentially
introducing recall and other information bias. Finally, we could not perform a meta-regression
for the determinants of unintended pregnancy among women using substances due to the
differences in the classifications of variables and lack of data for a few potential predictor
variables.

Public Health Implications and Future Recommendations
Rates of unintended pregnancy have remained high in the US during the past decade.
Unintended pregnancy is associated with poor well-being of women and their families and
substantial economic, health care, and individual costs. 3 Among women of childbearing age,
substance use has increased the risk for unintended pregnancy and poor health outcomes.Error!
Bookmark not defined.

Given the high prevalence of substance use and the risk of unintended

pregnancy among women of childbearing age, it is crucial to identify the prevalence and patterns
of substance and polysubstance use and their association with unintended pregnancy.15
Our studies explored the association between unintended pregnancy and substance and
polysubstance use. A high prevalence of substance use and unintended pregnancy was found
with an increased likelihood of unintended pregnancy among substance users. Women with
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substance use suffer from poor sexual and reproductive health. They encounter individual and
systemic challenges, including medical and psychological comorbidities, neglect and abuse,
mistrust of healthcare services, guilt, denial, and embarrassment regarding substance use, fear of
losing child custody, and poor access to family planning services. 301,302 These high-risk
situations indicate the significance of recognizing and reducing substance use among women of
childbearing age and facilitating effective contraceptive use among women tending to avoid
pregnancy. Healthcare providers must be aware of the women's unique needs and implications
surrounding substance use. 303
The current study's findings revealed inadequate PNC and low contraception use among
all substance-using women, specifically illicit and recreational drug users, thus supporting the
evidence of poor reproductive health among substance-using women. 304 The preconception
period is a critical time in women’s life to promote healthy behavior that can significantly
improve maternal and child health outcomes. 305 Implementing interventions to educate them on
the harmful effects of the substance, screening women for substance use, and encouraging
substance users for effective contraception use can significantly improve maternal and child
health outcomes. 306
Our study also noted a high prevalence of polysubstance use among women of
childbearing age and suggested the need for interventions addressing this serious concern. The
advocates of maternal and child, including the United States Preventive Services Task Force
(USPSTF) 307, CDC 308, and American College of Obstetricians and Gynecologists (ACOG) 309
recommend universal screening of women of childbearing age. There is evidence suggesting the
benefits of screening and brief interventions leading to a reduction in alcohol use, smoking, and
illicit drug use 310,311,312.
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Current studies also looked into the sociodemographic and mental health determinants of
unintended pregnancy among substance-using women. It was found that younger women, urban
living, lower education levels, poverty, marital status other than married, abuse, depression, and
anxiety were significantly and positively associated with unintended pregnancy. These findings
indicate the need for appropriate educational, screening and treatment efforts to identify the
women in need and provide treatment services integrated with family planning services. 313
Prevention and treatment efforts should consider the significant determinants of health. These
include social-economic factors, social support, family structure, and cultural norms. 314 Effective
screening plays a vital role in providing data regarding these factors and information on mental
health, 315 physical or emotional abuse, 316 childhood adversity 317 that are known determinants of
substance use, and poor reproductive health among women. Screening and assessment from a
perspective affirming the cultural values and beliefs facilitate the women's engagement in the
screening leading to the treatment process. 318 In addition to cultural differences, women from
minorities, racial/ethnic groups, living in rural areas, and not speaking English experience unique
challenges while pursuing substance use treatment. 319 A customized supportive therapy aimed to
address the barriers identified in the screening and assessment process may help women contact
and stay in the treatment services. 320
The substance-using women often report poor access to healthcare and family planning
services. 321 One of the barriers to accessing health care and family planning services is the social
stigma of substance use. 322 Women with substance use experience social and structural
stigma. 323 Other barriers reported in the literature include misconceptions about contraceptive
use, limited social support, health insurance, lack of transportation, intimate partner violence,
and trauma. A qualitative study conducted among physicians suggested patient-centered

81

Shafique Dissertation

communication and shared decision-making to improve contraception access and use among
substance use women to address these issues. 324
The results of SR with MA also have implications for future research. Our findings
recommend a more rigorous methodology to improve the study quality for future research. It is
also suggested that future studies focus on improving the reporting regarding potential sources of
bias. There is also a need for a precise gauge for variables prone to reporting bias like substance
use and pregnancy intention to the recall bias. Additional rigorous prospective research is needed
to address current studies' design and methodological limitations and improve reporting bias.
Given the high prevalence of illicit and recreational drug use among women of childbearing age,
the risk of unintended pregnancy, and their impact on maternal and child health, it is necessary to
prioritize this pressing public health concern. Our findings also support the need for evidencebased and culturally sensitive intervention to prevent unintended pregnancy and improve
maternal and child health outcomes.
Conclusion
Our findings from the large population-based sample of the US women of childbearing
age substantiated that preconception substance and polysubstance use are significantly and
positively associated with unintended pregnancy. Our investigations also found that younger age,
urban living, lower educational attainment, marital status other than married, annual income
<FPL, physical or emotional abuse, poor mental health, i.e., having depression or anxiety, were
significant determinants of unintended pregnancy among substance-using women. The results of
SR with MA suggest that the use of illicit and recreational drugs increases the likelihood of
unintended pregnancy. This study's findings highlight the need to address preconception
substance use among women of childbearing age, screening and counseling for substance use,
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and provision of effective contraception methods among women at risk to reduce unintended
pregnancy and associated adverse effects on maternal and child health.
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Tables
Chapter 2
Table 1(a). Background, demographics, and preconception substance use among the
women of childbearing age, PRAMS, 2016-17 (N=74,543)
Maternal Characteristics
Rurality
Urban
Rural
Race
Asian
White
Black
Others
Ethnicity
Hispanic
Non-Hispanic
Age
<=17
18-24
25-35
35+
Mean Age (SD)yrs.
Range yrs.
Education
Less than high school
High school only
Some college
Graduate
Marital status
Married
Others
Income to Need Ratio
Below FPL
At/ above FPL
Insurance
Medicaid
Others
No insurance
Kessner Index
Adequate PNC
Intermediate PNC
Inadequate PNC

Unweighted
count

Weighted
%

(95 % CI)

SE

58954
14535

78.3
21.7

77.8 - 78.7
21.3 – 22.12

0.2
0.2

4976
42695
13581
10747

5.9
69.6
14.8
9.7

5.7 – 6.2
69.1 – 70.1
14.4 – 15.2
9.3 - 10.0

0.1
0.3
0.2
0.2

13423
58781

19.7
80.3

19.2 – 20.1
79.9 – 80.8

0.2
0.2

1004
16806
43373
13358
23.48(5.8)
12-46

1.3
22.0
58.9
17.8

1.2 – 1.5
21.5 – 22.5
58.3 – 59.4
17.4 – 18.3

0.1
0.2
0.3
0.2

9848
17947
21083
73784

12.9
24.1
26.8
36.2

12.5 – 13.3
23.6 – 27.3
26.3 – 27.3
35.6 – 36.7

0.2
0.3
0.3
0.3

44393
30077

62.1
37.9

61.6 – 62.6
37.4 – 38.4

0.2
0.2

18078
41999

27.7
72.3

27.2 – 28.3
71.7 – 72.8

0.3
0.3

20894
44311
9338

23.3
62.7
14.1

22.8 – 23.7
62.2 – 63.3
13.7 – 14.5

0.2
0.2
0.3

50298
14350
4472

68.5
19.1
5.8

68.0 – 69.1
18.6 – 19.6
5.6 – 6.1

0.3
0.2
0.1

p-value
<.001
<.001

<.001
<.001

<.001

<.001
<.001
<.001

<.001
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Unknown PNC
Pregnancy Intention
Intended
Unintended
Mistimed
Unwanted
Ambivalent
Preconception
contraception Use
Yes
No
Depression/Anxiety
Yes
No
Prior Live Births
Yes
No
Abuse
Yes
No
ACE scores
0
1-3
4+
Smoking
Yes
No
Alcohol consumption
Yes
No
Binge drinking
Yes
No
Nicotine/Tobacco
Yes
No
Cannabis
Yes
No
Illicit/recreational Drugs
Yes
No
OTC pain relief
Yes
No
Prescription opioids

5423

6.6

6.3 – 6.8

0.1

42302
30997
14196
4722
12079

59.0
41.0
19.5
6.2
15.3

58.5 – 59.6
40.0 – 41.5
19.0 – 20.0
5.9 – 6.5
14.9 – 15.7

0.3
0.3
0.2
0.1
0.2

10254
14985

41.0
59.0

40.0 – 41.9
58.1 – 60.0

0.5
0.5

13559
60383

17.3
82.7

16.9 – 17.7
82.3 – 83.1

0.2
0.2

45291
29072

61.5
38.5

61.0 - 62.1
37.9 – 39.0

0.3
0.3

24315
23724

45.9
54.1

45.2 – 46.6
53.4 – 54.8

0.4
0.4

3282
2851
439

51.6
41.8
6.6

49.8 – 53.4
40.0 – 43.6
5.8 - 7.6

0.9
0.9
0.5

13976
59445

17.4
82.6

17.0 - 17.8
82.2 – 83.0

0.2
0.2

39831
33392

56.6
43.4

56 – 57.1
42.9 – 44.0

0.3
0.3

3811
8258

31.8
68.2

30.6 – 33.0
67.0 – 69.4

0.6
0.6

7955
65465

10.6
89.4

10.2 – 11.0
89.0 – 89.8

0.2
0.2

1986
15022

10.0
90.0

9.4 – 10.7
89.3 – 90.6

0.3
0.3

563
15920

4.2
95.8

3.7 – 4.8
95.2 – 96.3

0.3
0.3

9741
4544

70.1
29.9

68.9 – 71.2
28.8 – 31.1

0.6
0.6

<.001

<.001

<.001
<.001
<.001
<.001

<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
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Yes
848
5.2
4.7 – 5.8
0.3
No
15612
94.8
94.2 – 95.3
0.3
Prescription
<.001
antidepressants
Yes
165
7.1
6.1 – 8.2
0.5
No
2156
92.9
91.8 – 93.9
0.5
P-value based on chi-square test statistics. SE=standard error. FPL=Federal Poverty Level.
Adverse Childhood Experiences (ACE) scores were calculated from maternal childhood
experiences. Binge drinking defined as ≥ 4 drinks in 2 hours; Over the Counter (OTC) pain relief
included aspirin, Tylenol, Advil, or Aleve; prescription opioids defined as hydrocodone,
oxycodone, or codeine; prescription antidepressants defined as prescribed antidepressants and
anti-anxiety medications.
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Table 2(a). Association between pregnancy intention and preconception substance use,
PRAMS, 2016-17 (N=74,543)
Substance Use types

Smoking
No Smoking
Cigrettes /day
No smoking
Moderate smoking
Heavy smoking
Alcohol Consumption
No drinking
Drinks/Week
No drinking
Moderate
Heavy
Binge Drinking
No
Nicotine/tobacco
No
Cannabis
No
Illicit/recreational drugs
No
OTC Pain relief
No
Prescription opioids
No
Prescription antidepressants
No

Odd ratios (95% CI)
Unadjusted
Adjusted*
2.3
(2.2 – 2.5)
Ref

1.5a
(1.4 – 1.6)
Ref

Ref
1.8
(1.5 – 2.1)
2.3
(1.9 – 2.8)
0.8
(0.8 – 0.9)
Ref

Ref
1.5b
(1.3 – 1.8)
1.9
(1.5 – 2.3)
1.05c
(1.0 – 1.1)
Ref

Ref
1.01
(1.0 – 1.1)
1.5
(1.2 – 1.8)
1.4
(1.3 – 1.6)
Ref
2.0
(1.9 – 2.2)
Ref
2.4
(1.6 – 2.8)
Ref
2.6
(2.3 – 3.2)
Ref
0.88
(0.8 – 0.99)
Ref
1.7
(1.3 – 2.1)
Ref
1.3
(1.0 – 1.8)
Ref

Ref
1.2d
(1.1 – 1.2)
1.5
(1.2 – 1.8)
1.2e
(1.04 – 1.4)
Ref
1.4f
(1.3 – 1.5)
Ref
1.9g
(1.5 – 2.3)
Ref
1.7h
(1.2 – 2.4)
Ref
1.0i
(0.9 – 1.1)
Ref
1.4j
(1.02 – 1.9)
Ref
1.8k
(1.1 – 3.0)
Ref
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Moderate smoking= <10 cigarettes/day; Heavy smoking= ≥10 cigarettes/day; moderate
drinking= up to 7 drinks/week, heavy drinking= 8-14 drinks/week; Binge drinking = ≥4 drinks in
2 hours.
a,b,k,f
Adjusted for maternal age, race, education, marital status, rurality, income to need ratio and
depression/anxiety
c
adjusted for maternal age, race, income to need ratio and smoking
d,e,g,h,j
Adjusted for maternal age, race, education, marital status, rurality, income to need ratio
i
adjusted for maternal age and race

88

Shafique Dissertation

Table 3(a): Distribution of pregnancy intention subtypes by preconception substance use,
PRAMS, 2016-17 (N=74,543)
Substance use
Smoking
Yes
No
Number of cigs. /day
No smoking
Moderate
Heavy
Alcohol consumption
Yes
No drinking
Drinks /week
No drinking
Moderate
Heavy drinking
Binge drinking
Yes
No
Nicotine/Tobacco
Yes
No
Cannabis
Yes
No
Illicit/recreational drugs
Yes
No
OTC Pain relief
Yes
No
Prescription opioids
Yes
No
Prescription
antidepressants
Yes
No

Intended

Pregnancy Intention
weighted %
Ambivalent Mistimed

p-value
Unwanted

42.0
62.8

24.0
13.4

24.0
18.5

10.0
5.3

58.3
44.0
37.5

15.2
22.3
28.0

20.5
24.6
22.3

6.0
9.2
12.3

60.6
57.3

14.5
16.1

19.1
20.0

5.8
6.7

62.0
61.0
52.2

13.4
14.4
17.5

18.7
19.0
22.6

6.0
5.7
7.7

54.9
64.2

16.7
14.0

22.4
17.0

5.9
4.8

43.6
61.0

19.3
14.7

27.6
18.5

9.5
5.8

38.3
59.6

22.4
15.0

28.6
19.4

10.7
6.0

34.0
57.7

26.4
15.6

26.8
20.3

12.7
6.4

57.4
54.5

15.7
16.5

20.3
22.0

6.6
7.0

44.2
57.5

19.1
16.0

24.0
20.4

12.8
6.2

50.0
56.5

27.3
19.7

19.2
17.4

3.5
6.3

<.001
<.001

<.001
<.001

<.001
<.001
<.001
<.001
0.195
<.001
0.054

P-vales based on chi-square statistics. Percentages presented in table as row percentages;
individual percentages may not total 100 due to rounding. Bold text indicates a statistical
significance with a p-value<0.05.
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Moderate smoking= <10 cigarettes/day; Heavy smoking= ≥10 cigarettes/day; moderate
drinking= up to 7 drinks/week, heavy drinking= 8-14 drinks/week; Binge drinking = ≥4 drinks in
2 hours.
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Table 4(a). Unadjusted and adjusted ORs (95%CI) for pregnancy intention subtypes and
preconception substance use, PRAMS, 2016-17 (N=74,543)
Substance Use

Unadjusted OR (95% CI)
Ambivalent Mistimed Unwanted
Smoking
2.7
1.9
2.8
(2.5 – 2.9)
(1.7 – 2.1) (2.5 – 3.2)
No smoking
Ref
Ref
Ref
Moderate smoking
1.9
1.6
2.0
(1.5 – 2.5)
(1.3 – 2.0) (1.4 – 2.9)
Heavy smoking
2.8
1.7
3.1
(2.2 – 3.6)
(1.3 – 2.1) (2.1 - 4.7)
Alcohol
0.85
0.9
0.8
(0.8 – 0.9)
(0.8 – 1.0) (0.7 – 0.9)
No drinking
Ref
Ref
Ref
Moderate
1.1
1.0
0.9
(1.0 – 1.2)
(0.9 – 1.6) (0.8 – 1.2)
Heavy
1.5
1.4
1.5 (1.1 –
(1.3 – 1.9)
(1.1 – 1.7)
2.1)
Binge Drinking
1.4
1.5
1.4
(1.2 – 1.6)
(1.3 – 1.8) (1.1 – 1.8)
No
Ref
Ref
Ref
Nicotine or
1.8
2.1
2.3
tobacco
(1.6 – 2.0)
(1.9 – 2.3) (2.0 – 2.6)
No
Ref
Ref
Ref
Cannabis
2.3
2.3
2.8
(1.9 – 2.8)
(1.9 – 2.7) (2.2 – 3.7)
No
Ref
Ref
Ref
Illicit/recreational
2.9
2.2
3.4
drugs
(2.0 – 4.1)
(1.6 – 3.1) (2.2 – 5.3)

Adjusted* OR (95%CI)
Ambivalent Mistimed Unwanted
1.7
1.2
1.8
(1.6 – 1.9)
(1.1 – 1.4) (1.6 – 2.1)
Ref
Ref
Ref
1.6
1.4
1.5
(1.2 – 2.1)
(1.1 – 1.8) (1.0 – 2.3)
2.2
1.4
2.1
(1.7 – 3.0)
(1.1 – 1.8) (1.3 – 3.2)
1.0
1.2
0.9
(0.9 – 1.1)
(1.1 – 1.3) (0.8 – 0.9)
Ref
Ref
Ref
1.5
1.4
1.4
(1.2 – 1.7)
(1.2 – 1.6) (1.3 – 2.7)
2.0 (1.5 –
1.8 (1.4 – 1.9 (1.3 –
2.6)
2.3)
2.7)
1.1
1.3
1.1
(1.0 – 1.4)
(1.0 – 1.5) (0.9 – 1.5)
Ref
Ref
Ref
1.3
1.4
1.3
(1.2 – 1.5)
(1.3 – 1.6) (1.2 – 1.5)
Ref
Ref
Ref
1.8
1.7
2.3
(1.4 – 2.2)
(1.3 – 2.1) (1.7 – 3.2)
Ref
Ref
Ref
1.7
1.5
1.9
(1.1 – 2.6)
(1.01 –
(1.1 - 2.3)
2.3)
No
Ref
Ref
Ref
Ref
Ref
Ref
OTC Pain relief
0.9
0.9
0.9
1.5
1.4
1.4
(0.7 – 1.1)
(0.8 – 1.0) (0.7 – 1.1)
(1.2 – 1.8)
(1.2 – 1.7) (1.1 – 1.9)
No
Ref
Ref
Ref
Ref
Ref
Ref
Prescription
1.6
1.5
2.7
1.2
1.3
2.1
opioids
(1.1 – 2.1)
(1.1 – 2.1) (1.8 – 4.0)
(0.8 – 1.8)
(0.9 – 2.0) (1.3 – 3.2)
No
Ref
Ref
Ref
Ref
Ref
Ref
Prescription
1.6
1.2
0.6
2.1
1.7
0.7
antidepressants
(1.1 – 2.3)
(0.8 – 1.9) (0.3 – 1.4)
(1.2 – 3.7)
(1.0 – 3.1) (0.2 – 1.9)
No
Ref
Ref
Ref
Ref
Ref
Ref
*Adjusted for maternal age, race, ethnicity, education, marital status, rurality, income to need
ratio, and substance use
Moderate smoking= <10 cigarettes/day; Heavy smoking= ≥10 cigarettes/day; moderate
drinking= up to 7 drinks/week, heavy drinking= 8-14 drinks/week; Binge drinking = ≥4 drinks in
2 hours
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Table 1(b) Maternal sociodemographic characteristics stratified by preconception
substance use PRAMS 2016-17
Characteristics

Rurality
Urban
Rural
Race/Ethnicity
Asian
Non-Hispanic White
Hispanic White
Black
Others
Age
≤17
18-24
25-35
35+
Education
≤HS
Only HS
Some College
Graduate
Income to Need
ratio
<FPL
At/above FPL
Marital status
Married
Others
Depression/Anxiety
No
Yes
Abuse
No
Yes
Pregnancy Intention
Intended

All women

Alcohol

Tobacco/Nicotin
e

Prescription
Opioids

Illicit/Recrea
tional Drugs

N (Wt.%)
N=74543

N (Wt.%)
N=39831
(56.6)

N (Wt. %)
N=17535
(22.1)

N (Wt. %)
N=848
(5.2)

N (Wt. %)
N=1886
(10.8)

58954 (78.3)
14535 (21.7)

31307 (78.2)
7968 (21.8)

13830 (78.6)
3431 (21.4)

575 (76.7)
198 (22.9)

1290 (76.2)
476 (23.8)

4976 (5.9)
34367 (56.9)
8124 (12.7)
13581 (14.8)
10747 (9.7)

154 (3.3)
22413 (68.3)
3299 (9.3)
6004 (11.9)
4842 (7.2)

359 (1.9)
8746 (64.0)
1169 (8.1)
3480 (16.9)
3139 (9.1)

14 (1.0)
352 (68.3)
30 (2.8)
164 (18.2)
214 (9.6)

10 (0.8)
888 (73.1)
43 (2.5)
303 (15.3)
363 (8.4)

1004 (1.3)
16806 (22.0)
43373 (58.9)
13358 (17.8)

153 (0.3)
7628 (18.4)
24814 (63.1)
7234 (18.2)

224 (1.4)
5623 (31.7)
9615 (55.3)
2071 (11.5)

16 (2.0)
219 (23.3)
485 (60.4)
128 (14.3)

43 (2.1)
680 (35.0)
975 (52.3)
188 (10.5)

9848 (12.9)
17947 (24.1)
21083 (26.8)
24906 (36.2)

2656 (5.9)
7764 (19.3)
12349 (29.2)
16740 (45.6)

3006 (16.0)
6072 (34.1)
5882 (33.3)
2416 (16.6)

147 (15.4)
297 (34.3)
279 (33.9)
116 (16.5)

312 (15.1)
675 (39.2)
621 (33.0)
262 (12.7)

18078 (27.7)
41999 (72.3)

7520 (19.6)
26136 (80.4)

6569 (41.6)
7667 (58.6)

337 (46.4) *
332 (53.6)

914 (53.3) *
744 (46.7)

44393 (62.1)
30077 (37.9)

24978 (65.6)
14815 (34.4)

6177 (38.6)
11320 (61.4)

314 (40.6)
533 (59.4)

503 (31.4)
1379 (68.6)

60383 (82.7)
13559 (17.3)

31688 (81.0)
7943 (19.0)

11682 (69.0)
5737 (31.0)

526 (61.5)
318 (38.5)

1141 (62.5)
734 (37.5)

23724 (54.1)
24315 (45.9)

14491 (55.4)
14433 (44.6)

4410 (47.2)
6107 (52.8)

174 (31.4)
420 (68.8)

397 (41.8)
755 (58.2)

42302 (59.0)

23212 (60.6)

7218 (43.1)

371 (44.2)

652 (34.9)
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Unintended
Contraception use
No
Yes
Kessner Index
Adequate PNC
Intermediate PNC
Inadequate PNC
Unknown PNC

30997 (41.0)

16100 (39.4)

10030 (56.9)

460 (55.8)

1195 (65.1)

14985 (59.0)
10254 (41.0)

7610 (58.7)
5357 (41.3)

5281(63.3)
2999 (36.7)

162 (58.8)
105 (41.2)

437 (74.2)
194 (25.8)

50298 (68.5)
14350 (19.1)
4472 (5.8)
5423 (6.6)

28670 (73.5)
6516 (15.7)
1790 (4.2)
2855 (6.6)

4960 (64.5)
1728 (19.8)
615 (7.4)
652 (8.2)

529 (63.2)
194 (22.1)
78 (7.2)
47 (8.4)

307 (55.7)
137 (23.6)
80 (11.0)
39 (9.8)

*Chi-squared p-value NS (>.05). HS= High school, FPL = Federal Poverty Level, Abuse status
was defined as physical/emotional abuse. Tobacco/Nicotine included smoking, hookah,
electronic cigarettes, cigars, cigarillos, nicotine, and betel nut. Prescription opioids included
Hydrocodone, and Oxycodone, Codeine. Illicit/Recreational drugs included Adderall, Marijuana,
synthetic marijuana, Methadone, Heroine, Amphetamine, Cocaine, Tranquillizers, and
Hallucinogens.
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Table 2(b) Association of sociodemographic characters with pregnancy intention among
women using Alcohol PRAMS 2016-17 (N=74,543)
Characters

Pregnancy Intention
N (Weighted %)
Unintended

Intended

13221 (40.5)

17649 (59.5)

Rural
Race/Ethnicity

2877 (36.6)

5009 (63.4)

Asian
Non-Hispanic White

489 (33.4)
7332 (33.5)

1027 (66.6)
14814 (66.5)

Hispanic White

1533 (45.9)

1730 (54.1)

Black

3746 (63.4)

2165 (36.6)

Others

2416 (50.3)

2356 (49.7)

Rurality
Urban

Age (Years)
≤17

130 (89.6)

19 (10.4)

18-24

4786 (63.0)

2745 (37.0)

25-35

8985 (35.1)

15502 (64.9)

35+

2197 (29.7)

4946 (70.3)

Education
<High School

1569 (61.4)

1033 (38.6)

High School only

4345 (56.0)

3297 (44.0)

Some college

5918 (48.5)

6243 (51.5)

Graduate

4138 (24. 0)

12450 (76.0)

Income to need ratio
<FPL

4925 (66.0)

2479 (34.0)

At/above FPL

8580 (32.5)

17262 (67.5)

p-value

<.001

<.001

<.001

<.001

<.001

Odds Ratios (95% CI)
Unadjusted

Adjusted*

1.2
(1.1 – 1.3)
ref

1.2
(1.1 – 1.3)
ref

ref
1.00
(.84 - 1.12)
1.7
(1.4 – 2.1)
3.4
(2.9 – 4.2)
2.02
(1.7 – 2.4)

ref
0.8
(0.7 – 1.0)
0.9
(0.7 – 1.0)
2.1
(1.7 – 2.6)
1.1
(0.9 – 1.4)

20.4
(8.4 – 49.3)
4.04
(3.6 – 4.5)
1.3
(1.2 – 1.4)

7.0
(1.9 – 25.3)
2.1
(1.8 – 2.3)
1.1
(1.01 – 1.2)

5.0
(4.3 – 5.8)
4.0
(3.7 – 4.4)
3.0
(2.8 – 3.2)
ref

2.1
(1.7 – 2.5)
2.3
(2.0 – 2.6)
2.1
(1.9 – 2.3)
ref

4.0
(3.7 – 4.4)
ref

2.2
(1.9 – 2.4)
ref
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Marital status
Married
Others

6594 (26.2)
9485 (64.8)

18089 (73.8)
5107 (35.2)

Depression/anxiety
No
Yes

11948 (37.3)
4026 (48.4)

19297 (62.5)
3809 (51.6)

Abuse
No
Yes

4903 (32.8)
5534 (37.8)

9460 (67.2)
8757 (62.2)

FPL=Federal Poverty Level.

<.001

<.001

<.001

ref
5.18
(4.8 – 5.6)

ref
3.2
(2.9 – 3.5)

ref
1.6
(1.5 – 1.7)

ref
1.3
(1.2 – 1.4)

ref
1.2
(1.2 – 1.3)

ref
0.96
(0.9 – 1.04)

Weighted percentages presented in tables as row percentages. P-value based on chi-square. Bold
text indicates a statistically significant with a p-values <0.05. *Adjusted for Rurality, age,
income, marital status, education and having depression/anxiety.
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Table 3(b) Association of socio-demographic characters with pregnancy intention among
women using Tobacco/ Nicotine products, PRAMS 2016-17 (N=17,535)
Characters

Pregnancy Intention
N (Weighted %)
Unintended Intended

Rurality
Urban

8150 (57.9)

5426 (42.1)

Rural

1880 (54.9)

1518 (45.1)

Race/Ethnicity
Asian
Non-Hispanic White

173 (48.2)
4600 (53.3)

179 (51.8)
4023 (46.7)

Hispanic White

672 (58.0)

484 (42.0)

Black

2331 (68.0)

1080 (32.0)

Others

1919 (62.2)

1169 (37.8)

Age
≤17

193 (87.7)

30 (12.3)

18-24

375 (67.0)

1788 (33.0)

25-35

5089 (52.6)

4364 (47.4)

35+

989 (45.8)

1036 (54.2)

Education
<HS

1909 (65.3)

1040 (34.7)

HS only

3748 (62.7)

2215 (37.3)

Some college

3391 (58.2)

2407 (41.8)

Graduate

887 (34.4)

1500 (65.6)

Income to need ratio
<FPL

4434 (69.4)

2033 (30.6)

At/above FPL

3706 (47.6)

3856 (52.4)

Marital status
Married

2434 (39.4)

3643 (60.6)

p-value

.033

<.001

<.001

<.001

<.001

<.001

Odd Ratios (95% CI)
Unadjusted

Adjusted

1.1
(1.01 – 1.3)
ref

1.2a
(1.02 – 1.3)
ref

ref
1.2
(0.9 – 1.7)
1.5
(1.03 – 2.1)
2.3
(1.6 – 3.2)
1.7
(.2 – 2.5)

ref
0.8b
(0.6 – 1.2)
0.9
(0.6 – 1.3)
1.5
(1.02 – 2.1)
1.03
(0.7 – 1.5)

8.4
(4.1 – 17.0)
2.4
(2.03 – 2.8)
1.3
(1.1 – 1.5)
ref

5.2c
(2.1 – 12.6)
1.8
(1.5 – 2.2)
1.2
(1.01 – 1.4)
ref

3.6
(2.9 – 4.3)
3.2
(2.7 – 3.7)
2.6
(2.3 – 3.1)
Ref

1.7d
(1.4 – 2.1)
2.1
(1.7 – 2.5)
2.0
(1.7 – 2.3)
Ref

2.5
(2.2 – 2.8)
ref

1.9e
(1.7 – 2.1)
ref

ref

ref
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Others
Depression/anxiety
No
Yes
Abuse
No
Yes

7575 (67.9)
6402 (54.9)
3561 (61.5)
2266 (51.0)
2448 (55.6)

3559 (32.1)
5092 (45.1)
2079 (38.5)
2089 (49.0)
2578 (44.4)

<.001

.005

FPL=Federal Poverty Level, HS=High School

3.2
(2.9 – 3.6)

2.4 f
(2.1 – 2.7)

ref
1.3
(1.2 – 1.5)

ref
1.1g
(1.01 – 1.3)

ref
1.2
(1.01 – 1.4)

ref
0.9h
(0.8 – 1.05)

Weighted percentages presented in tables as row percentages. P-value based on chi-square. Bold
text indicates a statistically significant with a p-values <0.05.
A, b, g ,h Adjusted for rurality, age, income, education, depression/anxiety
f adjusted for age, race/ethnicity, income, rurality, education
c adjusted for age, income, race/ethnicity
d e adjusted for age, income, education, depression/anxiety
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Table 4(b) Association of sociodemographic characters with pregnancy intention among
women using prescription opioids, PRAMS 2016 (N=848).
Characters

Pregnancy Intention
Weighted %
Unintended
Intended

Rurality
Urban

382 (66.8)

177 (33.2)

Rural

78 (35.9)

119 (64.1)

Race/Ethnicity
Asian

07 (62.1)

07 (37.9)

Non-Hispanic White
Hispanic White

180 (51.4)
17 (59.3)

166 (48.6)
13 (40.7)

Black

100 (66.9)

60 (33.1)

Others

121 (64.6)

87 (35.4)

Age
≤17

12 (85.9)

04 (14.1)

18-24

150 (68.0)

66 (32.0)

25-35

232 (50.4)

243 (49.6)

35+

66 (54.1)

58 (45.9)

Education
<HS

82 (55.3)

58 (44.7)

HS only

185 (62.1)

111 (37.9)

Some college

150 (57.1)

124 (42.9)

Graduate

37 (37.3)

75 (62.7)

Income to need ratio
<FPL

233 (71.2)

99 (28.8)

At/above FPL

143 (43.5)

182 (56.5)

p-value

<.001

0.042

.015

0.054

<.001

Odd Ratios (95% CI)
Unadjusted

Adjusted*

3.6
(1.9 – 6.4)
ref

3.5
(1.8 – 6.8)
ref

1.5
(0.3 – 7.8)
ref
1.3
(0.5 – 3.7)
1.9
(1.1 – 3.2)
1.7
(1.02 – 2.9)

5.6
(0.8 – 39)
ref
2.8
(1.00 - 7.7)
1.5
(0.8 – 3.2)
4.0
(1.9 – 8.5)

5.1
(1.2 – 21.6)
1.8
(0.8 – 3.9)
0.86
(0.43 – 1.7)
ref

NAC**
1.2
(0.4 – 3.5)
0.74
(0.3 – 1.6)
ref

2.0
(0.9 – 4.9)
2.7
(1.3 – 5.8)
2.2
(1.1 – 4.6)
ref

1.2
(0.3 – 4.2)
1.7
(0.6 – 4.7)
2.0
(0.8 – 5.2)

3.2
(1.9– 5.4)
ref

3.0
(1.6 – 5.7)
ref
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Marital status
Married
Others

111 (41.3)
348 (65.5)

196 (58.7)
175 (34.5)

Depression/anxiety
No
Yes

263 (49.3)
194 (65.6)

251 (50.7)
119 (34.4)

Abuse
No
91 (61.6)
82 (38.4)
Yes
225 (50.8)
190 (49.2)
FPL=Federal Poverty Level, HS=High School

<.001

<.006

.131

ref
2.6
(1.6 – 4.4)

ref
1.8
(1.01-3.4)

ref
1.9
(1.2 – 3.2)

ref
2.0
(1.05 - 3.9)

-

-

Abuse was not significantly associated with other SD variables so was not included in further
analysis. Weighted percentages presented in tables as row percentages. P-value based on chisquare. Bold text indicates a statistically significant with a p-values <0.05.* Adjusted for rurality,
income, race/ethnicity, and depression/anxiety. Marital status adjusted for income and rurality.
**NAC= Not able to calculate
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Table 5(b) Association of sociodemographic characters with pregnancy intention among
women using Illicit and recreational drugs, PRAMS 2016-17 (N=1886).
Characters

Pregnancy Intention
N (Weighted %)
Unintended
Intended

Rurality
Urban

943 (73.5)

315 (26.5)

Rural

252 (52.2)

217 (47.8)

Race/ethnicity
Non-Hispanic White
Hispanic White

542 (62.2)
31 (76.0)

331 (37.8)
11 (24.0)

Black

214 (73.6)

80 (26.4)

Others

286 (75.1)

97 (24.9)

Age
≤17

38 (97.0)

4 (3.0)

18-24

486 (74.2)

182 (25.8)

25-35

569 (58.6)

386 (41.4)

35+

102 (60.8)

80 (39.2)

Education
<HS

218 (71.2)

85 (28.8)

HS only

452 (68.4)

207 (31.6)

Some college

398 (68.2)

213 (31.8)

Graduate

116 (41.6)

142 (58.4)

Income to Need ratio
<FPL

656 (74.0)

237 (26.0)

At/above FPL

393 (54.3)

340 (45.7)

p-value

Odd Ratios (95% CI)
Unadjusted Adjusted*

<.001

.005

<.001

<.001

<.001

2.8
(1.8 – 4.3)
ref

2.7
(1.7 – 4.1)
ref

ref
1.9
(0.7 – 5.0)
1.7
(1.1 – 2.5)
1.8
(1.1 – 2.9)

ref
2.1
(0.4 –
11.3)
1.4
(0.8 – 2.3)
3.3
(1.9 – 5.8)

15.1
(2.0 –
112.4)
1.9
(0.9 – 3.06)
1.1
(0.5 – 2.2)
ref

11.3
(1.7 –
76.2)
1.8
(0.9 – 3.7)
1.05
(0.5 – 2.0)
ref

1.5
(0.7 – 3.5)
1.8
(1.0 – 3.5)
2.5
(1.3 – 4.7)
ref

1.5
(0.7 – 3.6)
1.7
(0.9 – 3.3)
2.3
(1.2 – 4.4)
ref

1.9
(1.2 – 3.1)
ref

2.2
(1.4 – 3.4)
ref
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Marital status
Married
Others
Depression/anxiety
Yes
No

212 (47.6)
981 (73.2)
514 (68.1)
675 (63.3)

281 (52.4)
370 (26.8)
207 (31.9)
440 (36.7)

Abuse
Yes
483 (61.7)
263 (38.3)
No
220 (60.1)
173 (39.9)
FPL=Federal Poverty Level, HS=High School

<.001

.241

ref
3.0
(2.1 -4.3)
-

ref
2.4
(1.4 – 3.9)
-

.764

-

-

Weighted percentages presented in tables as row percentages. P-value based on chi-square. Bold
text indicates a statistically significant with a p-values <0.05. Due to small number of women in
Asian category, it was combined with Others in Race/Ethnicity variable. *Adjusted for Rurality,
age, income, marital status, race/ethnicity.
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Chapter 3
Table 1 Maternal sociodemographic characteristics of women delivering a live birth,
stratified by Alcohol use and Smoking during preconception period; PRAMS 2016-17
Characteristics

All women

Alcohol

Heavy Binge
Drinking

Smoking

Heavy
Smoking

N (Wt.%)
N=74543

N (Wt. %)
N=3,937

N (Wt. %)
N=13,976
(17.4)

N (Wt. %)
N=4,303

Rurality
Urban
Rural

N (Wt.%)
N=39831
(56.6)

58954 (78.3)
14535 (21.7)

31307 (78.2)
7968 (21.8)

3081 (74.8)
854 (25.2)

11052 (78.8)
2709 (21.2)

3408 (77.6)
857 (22.4)

Race/Ethnicity
Asian
Non-Hispanic White
Hispanic White
Black
Others

4976 (5.9)
34367 (56.9)
8124 (12.7)
13581 (14.8)
10747 (9.7)

154 (3.3)
22413 (68.3)
3299 (9.3)
6004 (11.9)
4842 (7.2)

138 (3.2)
1842 (67.4)
326 (10.4)
364 (7.8)
833 (11.1)

224 (1.4)
7411 (68.9)
798 (6.8)
2490 (14.4)
2507 (8.4)

29 (0.5)
2906 (82.5)
126 (3.1)
455 (8.0)
560 (6.0)

Marital Status
Married
Others

44393 (62.1)
30077 (37.9)

24978 (65.6)
14815 (34.4)

2259 (63.4)
1671 (36.6)

4613 (36.4)
9330 (63.6)

1340 (33.0)
2942 (67.0)

Age (in years)
≤17
18-24
25-35
35+

1004 (1.3)
16806 (22.0)
43373 (58.9)
13358 (17.8)

153 (0.3)
7628 (18.4)
24814 (63.1)
7234 (18.2)

14 (0.4)
939 (21.0)
2431 (63.1)
553 (15.5)

168 (1.3)
4352 (30.8)
7747 (56.0)
1707 (12.0)

36 (0.8)
1265 (29.8)
2454 (56.4)
547 (13.1)

Education
<HS
Only HS
Some College
Graduate

9848 (12.9)
17947 (24.1)
21083 (26.8)
24906 (36.2)

2656 (5.9)
7764 (19.3)
12349 (29.2)
16740 (45.6)

323 (7.4)
879 (20.5)
1236 (27.7)
1484 (44.4)

2687 (18.1)
5154 (36.0)
4576 (33.0)
1437 (12.8)

906 (20.8)
1693 (38.0)
1422 (34.8)
234 (6.5)

18078 (27.7)
41999 (72.3)

7520 (19.6)
26136 (80.4)

720 (20.0)
2315 (80.0)

5656 (45.0) *
5695 (55.0)

1957 (50.4) *
1639 (49.6)

60383 (82.7)

31688 (81.0)

1309 (45.0)

2949 (41.0)

815 (36.6)

Income to Need
ratio
<FPL
At/above FPL
Depressive
symptoms
No
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Yes

13559 (17.3)

7943 (19.0)

1415 (55.0)

5185 (59.0)

1649 (63.4)

Kessner Index
Adequate PNC
Intermediate PNC
Inadequate PNC
Unknown PNC

50298 (68.5)
14350 (19.1)
4472 (5.8)
5423 (6.6)

28670 (73.5)
6516 (15.7)
1790 (4.2)
2855 (6.6)

2789 (70.2)
759 (20.3)
202 (4.8)
187 (4.7)

8321 (62.1)
3305 (22.0)
1267 (8.2)
1083 (7.7)

2461 (59.8)
1036 (23.1)
435 (8.5)
371 (8.6)

Abuse
No
Yes

23724 (54.1)
24315 (45.9)

14491 (55.4)
14433 (44.6)

1357 (57.9)
1364 (42.1)

3284 (46.0)
4834 (54.0)

971 (43.0)
1490 (57.0)

Birth control
No
Yes

14985 (59.0)
24315 (41.0)

7610 (58.7)
5357 (41.3)

930 (57.7)
680 (42.3)

4419 (64.4)
2430 (35.6)

1557 (70.0)
703 (30.0)

Pregnancy Intention
Intended
Unintended

42302 (59.0)
30997 (41.0)

23212 (60.6)
16100 (39.4)

2035 (55.0)
1848 (45.0)

5550 (42.0)
8193 (58.0)

1584 (37.5)
2647 (62.5)

Mistimed
Unwanted
Ambivalent

14196 (19.5)
4722 (6.2)
12079 (15.3)

7441 (19.1)
2505 (5.8)
6154 (14.5)

875 (22.4)
275 (5.8)
699 (16.8)

3186 (23.9)
1451 (10.1)
3556 (24.1)

906 (22.3)
538 (12.3)
1203 (27.9)

Alcohol
Consumption
No
Yes

33392 (43.4)
39831 (56.6)

-

-

4657 (30.1)
9149 (69.9)

1692 (35.0)
2565 (65.0)

Heavy/Binge
drinking
No
Yes

8042 (67.1)
3938 (32.9)

8042 (67.1)
3938 (32.9)

-

1515 (50.7)
1339 (49.3)

393 (50.7)
371 (49.3)

Smoking
No
Yes

59445 (82.6)
13976 (17.4)

30400 (78.5)
9149 (21.5)

2568 (69.1)
1339 (30.9)

-

-

Heavy Smoking
No
Yes

11466 (72.9)
4303 (27.1)

7790 (74.7)
2565 (25.3)

1123 (77.0)
371 (23.0)

9673 (69.0)
4303 (31.0)

-

Cannabis
No
Yes

15022 (90.0)
1986 (10.0)

8732 (87.1)
1511 (12.9)

1056 (70.5)
393 (29.5)

2609 (74.2)
1091 (25.8)

745 (68.2)
416 (31.8)

103

Shafique Dissertation

Illicit Drugs
No
Yes

15920 (95.8)
563 (4.2)

9276 (95.4)
346 (94.6)

1200 (95.6)
68 (4.4)

3504 (87.5)
378 (12.5)

1001 (82.2)
183 (17.8)

Tobacco/Nicotine
No
Yes

65465 (89.4)
7955 (10.6)

33902 (86.0)
5748 (14.0)

3123 (80.5)
788 (19.5)

9511 (67.0)
4396 (33.0)

2747 (63.1)
1535 (36.9)

3477 (89.6)
393 (10.4)

1018 (86.4)
163 (13.6)

Opioids
No
15612 (94.8)
9130 (95.0)
1196 (94.1)
Yes
848 (5.2)
480 (5.0)
69 (5.9)
HS=High School, FPL= Federal Poverty Level, PNC=Prenatal Care

*Chi-squared p-value (>.05). HS= High school, FPL = Federal Poverty Level, Abuse status was
defined as physical/emotional abuse. Depressive symptoms were defined as feeling depressed or
sad before pregnancy. Tobacco/Nicotine included smoking, hookah, electronic cigarettes, cigars,
cigarillos, nicotine, and betel nut. Prescription opioids included Hydrocodone, and Oxycodone,
Codeine. Illicit/Recreational drugs included Adderall, Marijuana, synthetic marijuana,
Methadone, Heroine, Amphetamine, Cocaine, Tranquillizers, and Hallucinogens.
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Table 2: Association of unintended pregnancy to co-use of alcohol and other substances in a
representative sample of US women of childbearing age, PRAMS 2016-17 (N=39,831)
Alcohol

Heavy Binge Drinking

Other substance

Odds Ratios

Adjusted Odds
Ratios*

Odds Ratios

Adjusted Odds
Ratios*

Smoking
(Yes vs. No)

2.36
(2.18 – 2.55)

1.5
(1.4 – 1.6)

2.6
(2.1 – 3.1)

1.9
(1.5 – 2.4)

Heavy smoking
(Yes vs. No)

1.47
(1.3 – 1.7)

1.3
(1.1 – 1.5)

1.6
1.01 – 2.3)

1.6
(1.0 – 2.5)

Cannabis
(Yes vs. No)

2.4
(1.9 – 3.0)

2.0
(1.6 – 2.4)

2.4
(1.7 – 3.5)

2.1
(1.4 – 3.1)

Tobacco/Nicotine
(Yes vs. No)

1.8
(1.4 – 2.2)

1.6
(1.4 – 1.7)

2.6
(2.1 – 3.3)

2.3
(1.7 – 3.1)

Illicit drugs
(Yes vs. No)

3.04
(2.1 – 4.4)

1.8
(1.1 – 2.7)

2.2
(1.1 – 4.4)

1.6
(0.6 – 3.9)

Opioids
1.4
1.3
2.4
1.4
(Yes vs. No)
(1.01 – 1.9)
(0.9 – 1.9)
(1.2 – 4.7)
(0.6 – 3.6)
*Adjusted for maternal age, race/ethnicity, education, income to need ratio, rurality.
Bold text indicates statistically significant effect size at alpha 0.05
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Table 3: Association of unintended pregnancy sub-types to preconception use of alcohol in
concert with other substances in a representative sample of US women of childbearing age,
PRAMS 2016-17 (N=39,831); multivariable logistic regression.
Crude ORs with 95%CI

Adjusted* ORs with 95% CI

Other
Substances
Smoking (Yes vs.
No)

Mistimed

Unwanted

Ambivalent

Mistimed

Unwanted Ambivalent

2.0
(1.8 – 2.2)

2.9
(2.5 – 3.4)

2.7
(2.4 – 2.96)

1.3
(1.1 – 1.4)

1.8
(1.5 – 2.1)

1.7
(1.5 – 1.9)

Heavy smoking
(Yes vs. No)

1.8
(1.4 – 2.4)

3.1
(1.9 – 4.8)

2.6
(1.9 – 3.5)

1.6
(1.2 – 3.9)

2.3
(1.4 – 3.9)

2.2
(1.6 – 3.1)

Cannabis
(Yes vs. No)

2.3
(1.8 – 2.9)

3.3
(2.5 – 4.6)

2.4
(1.9 – 3.1)

1.7
(1.4 – 2.2)

2.8
(2.0 – 3.8)

2.0
(1.5 – 2.6)

Tobacco/Nicotine
2.2
(Yes vs. No)
(1.9 – 2.5)

2.5
(2.1 – 3.0)

1.9
(1.7 – 2.2)

1.6
(1.4 – 1.8)

1.8
(1.5 – 2.3)

1.4
(1.3 – 1.7)

Illicit drugs
(Yes vs. No)

2.5
(1.6 – 4.0)

4.7
(2.7 – 8.2)

3.06
(1.9 – 4.8)

1.6
(1.0 – 2.6)

2.7
(1.4 – 5.1)

1.8
(1.04 – 3.1)

Opioids
(Yes vs. No)

1.4
(0.9 – 2.1)

3.1
(1.9 -5.1)

1.5
(1.0 – 2.2)

1.2
(0.7 – 2.0)

2.3
(1.3 – 4.0)

1.01
(0.6 – 1.7)

*Adjusted for maternal age, race/ethnicity, education, income to need ratio, rurality. Bold text
indicates statistically significant effect size at alpha 0.05
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Table 4: Demographic characteristics of women delivering a live birth, stratified by
patterns of polysubstance use during the preconception period (PRAMS 2016-17)
Characteristics

Alcohol
only

Alcohol and
Smoking

Alcohol &
Cannabis

N = 39,831
N (Wt. %)

N = 9,149
N (Wt. %)

N = 1,511
N (Wt. %)

Alcohol &
Illicit/recreational
drugs
N = 346
N (Wt. %)

Rurality
Urban
Rural

31307 (78.2)
7968 (21.8)

7210 (78.8)
1788 (21.2)

1069 (75.8)
372 (24.2)

261 (86.5)
75 (13.5)

Age
≤19
20-34
35+

975 (2.2)
31620 (79.6)
7234 (18.2)

478 (4.5)
7059 (77.7)
1612 (17.8)

103 (5.9)
1160 (76.7)
248 (17.4)

24 (3.8)
254 (77.2)
68 (19.0)

22413 (68.3)

4962 (70.4)

805 (70.5)

173 (81.3)

3299 (9.3)
6004 (11.9)
6388 (10.5)

577 (7.4)
1552 (12.7)
1707 (9.5)

71 (7.9)
201 (10.8)
231 (10.8)

10 (2.2)
29 (7.4)
90 (9.2)

Education
≤High School
Some college
Graduate

10418 (25.2)
12349 (29.2)
16740 (45.6)

4477 (46.8)
3347(36.6)
1258 (16.6)

638 (45.4)
524 (30.9)
333 (23.7)

169 (47.4)
120 (35.3)
50 (17.3)

Income
Below FPL
At/Above FPL

7520 (19.6)
26136 (80.4)

3256 (37.2)
4399 (62.8)

620 (39.8)
770 (60.2)

162 (46.0)
135 (54.0)

Marital status
Married
Others

24978 (65.6)
14815 (34.4)

3331 (40.1)
5799 (59.9)

562 (43.9)
943 (56.1)

91 (37.8)
255 (62.2)

Pregnancy
Intention
Intended
Unintended

23212 (60.6)
16100 (39.4)

3768 (37.2)
4399 (62.8)

590 (40.4)
892 (59.6)

103 (33.8)
232 (66.2)

Depressive
symptoms
No
Yes

14065 (53.0)
14896 (47.0)

2187 (44.3)
3451 (55.7)

329 (38.8)
647 (61.2)

71 (36.4)
149 (63.6)

Race/Ethnicity
Non-Hispanic
White
Hispanic White
Black
Others
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Chi-squared p-value (<.05). FPL=Federal poverty level, Depressive symptom=feeling sad or
depressed before pregnancy, Rurality=based on rural-urban codes by NCHS
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Table 5: Association of maternal sociodemographic factors to likelihood of unintended
pregnancy, stratified by preconception substance use pattern, PRAMS 2016-17 (N=39,831).
Characteristics

Alcohol
Only

Alcohol and
smoking

Alcohol &
Cannabis

(n=9149)

(n=1511)

Alcohol &
Illicit/recreational
drugs
(n=346)

AOR* (95%CI)

AOR* (95%CI)

AOR* (95%CI)

AOR* (95%CI)

Rurality
Rural
Urban

Ref
1.2 (1.1 – 1.3)

Ref
1.2 (1.1 – 1.5)

Ref
2.5 (1.6 – 3.9)

Ref
1.6 (0.6 – 4.4)

Age
≤19
20-34
35+

Ref
0.4 (0.3 – 0.6)
0.4 (0.2 – 0.5)

Ref
1.5 (1.0 – 2.2)
2.0 (1.3 – 3.0)

Ref
1.3 (0.6 – 2.8)
1.7 (0.7 – 4.1)

Ref
3.6 (0.4 – 33.5)
7.5 (0.7 – 78.1)

Race/Ethnicity
Non-Hispanic
White
Hispanic White
Black
Others

Ref

Ref

Ref

Ref

1.1 (0.9 – 1.2)
2.3 (2.1 – 2.7)
1.3 (1.1 – 1.4)

0.8 (0.6 – 1.2)
1.4 (1.1 – 1.7)
1.3 (1.0 – 1.7)

1.3 (0.6 – 2.8)
1.6 (0.9 – 2.9)
1.6 (0.8 – 3.3)

1.02 (0.3 – 3.6)
1.9 (0.6 – 6.0)

Education
≤High School
Some college
Graduate

2.6 (2.4 – 2.9)
2.3 (2.1 – 2.5)
Ref

2.8 (2.3 – 3.6)
2.6 (2.0 – 3.2)
Ref

2.6 (1.6 – 4.6)
2.9 (1.7 – 4.9)
Ref

2.3 (0.8 – 7.0)
7.2 (2.1 – 23.7)
Ref

Income
Below FPL
At/Above FPL

2.3 (2.1 – 2.6)
Ref

2.0 (1.6 – 2.3)
Ref

2.1 (1.3 – 3.4)
Ref

3.7 (1.6 – 9.0)
Ref

Marital status
Married
Others

Ref
3.2 (3.0 – 3.5)

Ref
2.4 (2.0 – 2.8)

Ref
2.8 (1.8 – 4.4)

Ref
1.7 (0.6 – 4.9)

1.2 (1.1 – 1.3)

1.4(1.1 – 1.6)

1.1 (0.6 – 1.8)

0.6 (0.2 – 1.6)

Ref

Ref

Ref

Ref

Depressive
Symptoms
No

*Adjusted for maternal age, race, ethnicity, income, rurality, and level of education. Bold text
indicates statistically significant Odds Ratio
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Chapter 4
Table 1: Risk of bias assessment by domain using Newcastle-Ottawa Scale for crosssectional, case-control, and cohort studies
Study

Study design

Besculides et al., 2004
Dott et al., 2009
Lundsberg et al., 2018
Lundsberg et al., 2020
Oulman et al., 2015
Paquette et al., 2017
Short et al., 2020
Wellings et al., 2013

Cross-sectional
Case-control
Prospective cohort
Cross-sectional
Cross-sectional
Cross-sectional
Cross-sectional
Cross-sectional

Selection
(Maxim. 5
stars)
****
***
****
**
****
****
***
***
3.4

Comparability
(Maxim. 2
stars)
*
**
*
*
**
*
*
*
1.25

Outcome/exposure
(Maxim. 3stars)
**
**
**
**
**
**
**
**
2.0
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Table 2. Characteristics of eligible studies (N=8 studies). SR with MA regarding the
association between maternal illicit and recreational drug use and the likelihood of
unintended pregnancy.
First author
(Publication
years)
Besculides et al.,
2004

Region

Study
design

Data
collection
period
1998-2001

Sample size

Population

Data source

NYC/US

Crosssectional

8886

Pregnant
women

Casecontrol

1997-2002

4094

Women who
gave live
births

MA,
CT/US

Cohort

2005-09

2654

Pregnant
women

Lundsberg et al.,
2020

CT/US

Crosssectional

2014-15

123

Pregnant
women

Office of
family health,
NYC, Dept.
of Health
&Mental
Hygiene
National Birth
Defects
Prevention
study
Hospital
based
research study
Questionnaire

Dott et al., 2009

US

Lundsberg et al.,
2018

Oulman et al.,
2015

Canada

Crosssectional

2005-2006

6421

Paquette et al.,
2017

Britain

Crosssectional

2010-12

4980

US

Crosssectional

2016

5676

Britain
(England,
Scotland,
Wales)

Crosssectional

2010-12

5686

Women of
childbearing
age
Women of
childbearing
age
Women who
gave live
births
Women of
childbearing
age

Short et al., 2020
Wellings et al.,
2013

Maternity
experience
survey
Natsal-3
PRAMS
Natsal-3
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Table 3. Description of the exposure and outcome variables from the eligible studies (N=8).
SR with MA regarding the association between maternal illicit and recreational drug use
and the likelihood of unintended pregnancy.
First author
(Publication
years)

Exposure/
Exposure
assessment

Besculides et
al., 2004

Smoking, alcohol, Drug use = 4% Pregnancy
drug use/
intention/
Question about
Self-reported
current
pregnancy’
intention
Smoking, alcohol, Illicit drugs =
Pregnancy
illicit drugs,
5.3%
intention/
vitamin intake /
Question about
Self-reported
current
pregnancy’
intention

Dott et al.,
2009

Prevalence of
illicit/recreati
onal drug use

Outcome/
outcome
assessment

Lundsberg et
al., 2018

Marijuana,
cocaine, smoking,
alcohol/
Self-reported

Marijuana =
6.5%, cocaine
= 1%

Lundsberg et
al., 2020

Tobacco, alcohol,
cannabis, illicit
drugs/ Selfreported
Smoking, alcohol,
drugs/ Selfreported

Cannabis =
21%, illicit
drugs = 12%

Illicit drugs
(Amphetamines,
cocaine, crack,
Ecstasy, Heroin,

Illicit drugs
Risky sexual
and cannabis = behaviors &
12.5%
Pregnancy
intention/LMUP

Oulman et
al., 2015

Paquette et
al., 2017

Drug use =
6.7%

Pregnancy
intention/
Question about
current
pregnancy’
intention
Pregnancy
intention &
perception/
LMUP
Pregnancy
intention/
Question about
current
pregnancy’
intention

Prevalence Determinants of
of
unintended
unintended
pregnancy
pregnancy
82.10%
10-19yrs,
OR:2.2), whitenon-Hispanic
(OR:1.67),
Unmarried
(OR:3.4)
40.00%
Age:<20years,
Non-Hispanic
Black race, <HS
education, Prev.
adverse pregnancy
outcome, smoking
(OR: 1.69)
37.20%
Preconception
substance use

67.50%

27.00%

5.30%
among
those using
drugs

substance use
including alcohol
(OR: 3.2) and
tobacco
Age:<20years
(OR: 4.4),
Immigrants
(OR:1.5), ≤HS
education
(OR:1.7), no
partner (OR: 3.2),
abuse (OR:1.3), 1
or more Prev.
pregnancies,
Substance use
Not reported since
primary outcome
of the study was
different
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Short et al.,
2020

Wellings et
al., 2013

LSD, Crystal
meth, other nonprescribed drugs)
Alcohol, tobacco,
marijuana/ Selfreported

Marijuana =
8%

Smoking, alcohol, Cannabis =
drugs, cannabis/
7.3%, Illicit
Self-reported
drugs = 5.8%

Pregnancy
intention/PRAMS
questions on
pregnancy
intention
Unplanned
pregnancy/LMUP

42.60%

45.20%

Not reported since
the primary
outcome of the
study was
different
Age:<20, First
intercourse before
age 16 (OR:2.8),
lower educational
attainment
(OR:1.98),
Substance use
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Table 4: Findings of included studies in SR and MA regarding the association between
illicit and recreational drug use during the preconception period and the likelihood of
unintended pregnancy (N=8 studies).
Study
Besculides et al.,
2004

ORs
2.13

AORs
1.4

Dott et al., 2009

-

3.2

Lundsberg et al.,
2018

-

1.6

Lundsberg et al
2020
Oulman et al., 2015

2.63

1.42

1.69

1.37

Paquette et al., 2017

2.61

2.39

Short et al., 2020

-

2.00

Wellings et al., 2013

-

3.41

LCI95% HCI95%
AORs adjusted for
0.96
2.05
Age, race/ethnicity, marital status,
contraceptive use, number of
previous pregnancies, alcohol, and
smoking.
2.26
4.53
Age, race, ethnicity, parity,
education, income, history of
pregnancy complications
1.05
2.43
Age, race/ethnicity, education,
relationship status, parity, medical
history
0.27
7.41
Demographics, pregnancy history,
mental health, substance use
1.05
1.79
Predictors of pregnancy intention
including demographics,
reproductive history
1.39
6.17
Age, sexual identity, number of
sexual partners
1.5
2.8
Demographics
1.64

7.11

Age
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Table 5: Individual and pooled effect size: Meta-analysis of the association of illicit and
recreational drug use during the preconception period and likelihood of unintended
pregnancy (N=8 studies).

Study
Besculides et al., 2004
Dott et al., 2009
Lundsberg et al., 2018
Lundsberg et al., 2020
Oulman et al., 2015
Paquette et al., 2017
Short et al., 2020
Wellings et al., 2013
Pooled
Statistics
I-squared
Cochran's Q
Chi2, p

ES
1.4
3.2
1.6
1.42
1.37
2.39
2
3.41

LCI 95%
0.96
2.26
1.05
0.27
1.05
1.39
1.5
1.64

HCI 95%
2.05
4.53
2.43
7.41
1.79
6.17
2.8
7.11

weight (%)
14.11003
16.7961
11.53442
0.740288
28.54151
3.656129
20.84685
3.77467

1.84441

1.380783

2.463709

100

65.70116
20.40886
0.004751

27.13366

83.85523
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Table 6: Influence analysis showing pooled effect size following removal of each eligible
study from the meta-analysis (Association of illicit and recreational drug use during the
preconception period and likelihood of unintended pregnancy, N=8 studies).

Excluded study
Besculides et al., 2004
Dott et al., 2009
Lundsberg et al., 2018
Lundsberg et al., 2020
Oulman et al., 2015
Paquette et al., 2017
Short et al., 2020
Wellings et al., 2013

Pooled
ES
1.929864
1.65026
1.878914
1.848011
2.077
1.826361
1.805485
1.800478

LCI
95%
1.388428
1.334204
1.337595
1.369058
1.546207
1.34078
1.250144
1.348917

HCI
95%
2.68244
2.04118
2.63930
2.49452
2.79001
2.48780
2.60752
2.40320

Cochran
Q
18.04647
8.813442
19.91034
20.31236
13.72716
19.92671
20.08201
17.60575

p
0.006117
0.184345
0.002873
0.002436
0.032837
0.002854
0.002678
0.007297

I
66.7525
31.92217
69.8649
70.46133
56.29102
69.88966
70.12251
65.92022
2

I 2 LCI
95%
25.8576
0
33.9127
35.44496
0
33.9764
34.5750
23.6892
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I 2 HCI
95%
85.0908
71.0375
86.2587
86.4838
81.1962
86.2680
86.3559
84.7802
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Table 7: Cumulative meta-analysis for the association of illicit and recreational drug use
during the preconception period and likelihood of unintended pregnancy, N=8 studies).
Study
Lundsberg et al., 2020
Short et al., 2020
Lundsberg et al., 2018
Paquette et al., 2017
Oulman et al., 2015
Wellings et al., 2013
Dott et al., 2009
Besculides et al., 2004

ES
1.42
1.976647
1.836357
1.885098
1.639707
1.706625
1.929864
1.84441

LCI 95%
0.271057
1.454588
1.433612
1.490366
1.356379
1.320853
1.388428
1.380783

HCI 95%
7.439017
2.686077
2.352245
2.384376
1.982217
2.205068
2.682441
2.463709

Cumulative
Weight (%)
0.74028811
21.58713753
33.12155862
36.77768797
65.31919509
69.09386535
85.8899694
100
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Initial records identified (n = 4,920)
•
•
•
•
•

PubMed (n = 566)
Scopus (n = 1,748)
Web of science (n = 1,929)
CINAHL (n = 514)
PsychINFO (n = 163)

Records excluded with reasons (n = 120)
Inappropriate outcome (n = 49)
Inappropriate study design (n = 9)
Inappropriate exposure (n = 22)
Inappropriate population (n = 5)
Reviews (n = 12)

Eligibility

Screening

Language not English (n =1)
Records selected after titles screening and
duplicates removed electronically/manually
(n = 142)

Full text articles assessed for eligibility
(n = 22)

Other regions (n = 8)
Duplicates (n = 7)

Records excluded with reasons (n =
14)
Inappropriate outcome (n = 2)
Inappropriate exposure (n = 5)

Inclusion

Inappropriate comparison (n = 4)
Inappropriate population (n = 3)
Articles included in meta-analysis (n = 8)

Figure1: Flow chart diagram describing the selection of studies included in the systematic
review and meta-analysis (SR and MA) for the association of illicit and recreational drug
use during the preconception period and likelihood of unintended pregnancy, N=8 studies).
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Figure 2: Forest Plot for the association of illicit and recreational drug use during the
preconception period and the likelihood of unintended pregnancy, N=8 studies).

Forest Plot

Study
Besculides et al 2004
Dott et al 2009
Lundsberg et al 2018
Lundsberg et al 2020
Oulman et al 2015
Paquette et al 2017
Short et al 2020
Wellings et al 2013

OR (95% CI)
% Weig
1.40 ( 0.96, 2.05) 14.1
3.20 ( 2.26, 4.53) 16.8
1.60 ( 1.05, 2.43) 11.5
1.42 ( 0.27, 7.41)
0.7
1.37 ( 1.05, 1.79) 28.5
2.39 ( 1.39, 6.17)
3.7
2.00 ( 1.50, 2.80) 20.8
3.41 ( 1.64, 7.11)
3.8
1.84 ( 1.38, 2.46)

Overall
Q=20.41, p=0.00, I2=66%
0

1.5

3

OR

4.5

6

100.0

7.5
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Figure 3: DOI Plot using the logarithm of Odds Ratio as the effect measure to examine the
association between illicit and recreational drug use during the preconception period and
the likelihood of unintended pregnancy, N=8 studies).
(LFK index = 2.66)
DOI Plot
LFK index: 2.66 (Major asymmetry)

0
0.2
0.4
0.6
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